<SEC-DOCUMENT>0001104659-25-002505.txt : 20250110
<SEC-HEADER>0001104659-25-002505.hdr.sgml : 20250110
<ACCEPTANCE-DATETIME>20250110154626
ACCESSION NUMBER:		0001104659-25-002505
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20250110
DATE AS OF CHANGE:		20250110

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GALAPAGOS NV
		CENTRAL INDEX KEY:			0001421876
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88880
		FILM NUMBER:		25522708

	BUSINESS ADDRESS:	
		STREET 1:		GEN DE WITTELAAN L11 A3
		CITY:			2800 MECHELEN
		STATE:			C9
		ZIP:			00000
		BUSINESS PHONE:		3215342900

	MAIL ADDRESS:	
		STREET 1:		GEN DE WITTELAAN L11 A3
		CITY:			2800 MECHELEN
		STATE:			C9
		ZIP:			00000

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GILEAD SCIENCES, INC.
		CENTRAL INDEX KEY:			0000882095
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				943047598
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		333 LAKESIDE DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		6505743000

	MAIL ADDRESS:	
		STREET 1:		333 LAKESIDE DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GILEAD SCIENCES INC
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <previousAccessionNumber>0001104659-19-041473</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: GILEAD SCIENCES, INC. -->
          <cik>0000882095</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>4</amendmentNo>
      <securitiesClassTitle>Ordinary Shares, no par value</securitiesClassTitle>
      <dateOfEvent>01/07/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001421876</issuerCIK>
        <issuerCUSIP>36315X101</issuerCUSIP>
        <issuerName>Galapagos NV</issuerName>
        <address>
          <com:street1>Generaal De Wittelaan L11 A3</com:street1>
          <com:city>Mechelen</com:city>
          <com:stateOrCountry>C9</com:stateOrCountry>
          <com:zipCode>2800</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Gilead Sciences, Inc.</personName>
          <personPhoneNum>650-574-3000</personPhoneNum>
          <personAddress>
            <com:street1>333 Lakeside Drive</com:street1>
            <com:city>Foster City</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>94404</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0000882095</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Gilead Sciences, Inc.</reportingPersonName>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>20981010.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>20981010.00</sharedDispositivePower>
        <aggregateAmountOwned>20981010.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>29.9</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
        <commentContent>Based on 65,897,071 ordinary shares, no par value, of Galapagos NV (the "Issuer") issued and outstanding as of December 31, 2023, as reported in the Issuer's Form 20-F filed with the U.S. Securities and Exchange Commission on March 28, 2024 (the "Form 20-F"), plus the 4,273,533 ordinary shares, no par value, of the Issuer that are issuable to Gilead Therapeutics A1 Unlimited Company pursuant to that certain Subsequent Gilead Warrant B of the Issuer based on the number of ordinary shares issued and outstanding as of December 31, 2023, as reported in the Form 20-F.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Gilead Therapeutics A1 Unlimited Company</reportingPersonName>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>L2</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>20981010.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>20981010.00</sharedDispositivePower>
        <aggregateAmountOwned>20981010.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>29.9</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
        <commentContent>Based on 65,897,071 ordinary shares, no par value, of the Issuer issued and outstanding as of December 31, 2023, as reported in the Issuer's Form 20-F, plus the 4,273,533 ordinary shares, no par value, of the Issuer that are issuable to Gilead Therapeutics A1 Unlimited Company pursuant to that certain Subsequent Gilead Warrant B of the Issuer based on the number of ordinary shares issued and outstanding as of December 31, 2023, as reported in the Form 20-F.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Ordinary Shares, no par value</securityTitle>
        <issuerName>Galapagos NV</issuerName>
        <issuerPrincipalAddress>
          <com:street1>Generaal De Wittelaan L11 A3</com:street1>
          <com:city>Mechelen</com:city>
          <com:stateOrCountry>C9</com:stateOrCountry>
          <com:zipCode>2800</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>EXPLANATORY NOTE:

This Amendment No. 4 to Schedule 13D (this "Schedule 13D/A") amends and supplements the statement on Schedule 13D originally filed with the Securities and Exchange Commission (the "SEC") on July 23, 2019, as amended by Amendment No. 1 thereto filed on August 29, 2019, Amendment No. 2 thereto filed on November 1, 2019 and Amendment No. 3 thereto filed on May 2, 2024 (the "Schedule 13D"), filed by Gilead Sciences, Inc., a Delaware corporation ("Gilead"), and Gilead Therapeutics A1 Unlimited Company, an unlimited liability company formed under the laws of Ireland and a wholly owned subsidiary of Gilead ("A1" and together with Gilead, the "Reporting Persons"), with respect to the ordinary shares, no par value (the "Ordinary Shares"), of Galapagos NV (the "Issuer").

This Schedule 13D/A is being filed to report the entry into the Separation Agreement, dated January 7, 2025 (the "Separation Agreement"), by and among the Issuer and the Reporting Persons. Except as expressly amended by this Schedule 13D/A, the Schedule 13D remains in effect.

This Schedule 13D/A amends and supplements the Schedule 13D with respect to the Ordinary Shares of the Issuer. The principal executive offices of the Issuer are located at Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium.</commentText>
      </item1>
      <item2>
        <filingPersonName>Item 2 of the Schedule 13D is hereby amended and replaced with the following:

This Schedule 13D is being filed by the Reporting Persons. The address of the principal business office of Gilead is 333 Lakeside Drive, Foster City, California, 94404. The address of the principal business office of A1 is 70 Sir John Rogerson's Quay, Dublin 2, Ireland.

The principal business of the Reporting Persons is to develop and commercialize innovative medicines in areas of unmet medical need and engage in any other activity or business which may be lawfully carried on by a corporation organized under such entity's jurisdiction of organization. The name, residence or business address, present principal occupation and citizenship of each director, executive officer and controlling person of Gilead and A1 is attached hereto as Exhibit 99.3.</filingPersonName>
        <principalBusinessAddress>See (a).</principalBusinessAddress>
        <principalJob>See (a).</principalJob>
        <hasBeenConvicted>During the last five years, neither the Reporting Persons, nor, to the knowledge of the Reporting Persons, any of the persons listed on Exhibit 99.3 hereto has been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>During the last five years, neither the Reporting Persons, nor, to the knowledge of the Reporting Persons, any of the persons listed on Exhibit 99.3 hereto was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</convictionDescription>
        <citizenship>See (a).</citizenship>
      </item2>
      <item3>
        <fundsSource>No amendment to this Item is being made.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>Item 4 is hereby amended and supplemented with the addition of the following:

Separation Agreement

On January 7, 2025, the Issuer and the Reporting Persons entered into the Separation Agreement, pursuant to which and subject to the terms and conditions set forth therein, the Issuer shall separate certain assets and liabilities into a new entity ("SpinCo") through a partial demerger in the sense of Article 12:8, 1deg of the Belgian Companies and Associations Code ("een met splitsinggelijkgesteldeverrichting / uneoperationassimilee a la scission"), following which the existing shareholders of the Issuer shall receive shares in SpinCo in the same proportion as their respective shareholdings in the Issuer (such transaction, the "Separation").

In the Separation, the Warrant held by the Reporting Persons shall be split into a subscription right for shares of the Issuer and for shares of SpinCo in accordance with the terms set forth in the Separation Agreement.

In the Separation Agreement, A1 has agreed to, and Gilead has agreed to cause A1 to, exercise its rights as a shareholder of the Issuer to attend any shareholder meeting of the Issuer to which proposals in relation to the Separation shall be submitted, and to vote all of its shares of the Issuer at such meetings to approve the Separation and other related matters, in each case if such Separation is in accordance with the terms of the Separation Agreement.

The foregoing summary is not complete and is qualified in its entirety by reference to the full text of the Separation Agreement, which is attached hereto as Exhibit 99.4 and incorporated herein by reference.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>No amendment to this Item is being made.</percentageOfClassSecurities>
        <numberOfShares>No amendment to this Item is being made.</numberOfShares>
        <transactionDesc>Except as set forth in Item 4 of this Schedule 13D/A or as previously disclosed in the Schedule 13D, neither the Reporting Persons nor, to the best knowledge of the Reporting Persons, any person named in Item 2 of this Schedule 13D/A has effected any transaction in Ordinary Shares during the past 60 days.</transactionDesc>
        <listOfShareholders>No person other than the Reporting Persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities beneficially owned by the Reporting Persons identified in this Item 5.</listOfShareholders>
        <date5PercentOwnership>Not applicable.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>Item 6 is hereby amended and supplemented with the addition of the following:

The information set forth above in Item 4 above with respect to the Separation Agreement is incorporated herein by reference.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Item 7 is hereby amended and supplemented with the addition of the following:

99.3 Directors and Executive Officers of Reporting Persons.

99.4 Separation Agreement, dated January 7, 2025, by and between Galapagos NV, Gilead Therapeutics A1 Unlimited Company and Gilead Sciences, Inc.</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Gilead Sciences, Inc.</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Andrew D. Dickinson</signature>
          <title>Andrew D. Dickinson, Executive Vice President and Chief Financial Officer</title>
          <date>01/10/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Gilead Therapeutics A1 Unlimited Company</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Aoife Marrinan</signature>
          <title>Aoife Marrinan, Director</title>
          <date>01/10/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>2
<FILENAME>tm252810d1_ex99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Directors and Executive Officers of Gilead</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All addresses are c/o Gilead Sciences,&nbsp;Inc., 333 Lakeside Drive,
Foster City, California, 94404.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Citizenship</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; width: 28%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal Occupation</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel P. O&rsquo;Day</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer, Chairman and Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacqueline K. Barton, Ph.D.</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professor Emerita, California Institute of Technology</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey A. Bluestone, Ph.D.</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer, Sonoma Biotherapeutics,&nbsp;Inc.</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sandra J. Horning, M.D.</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retired Chief Medical Officer, Roche,&nbsp;Inc.</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kelly A. Kramer</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retired Executive Vice President and Chief Financial Officer, Cisco Systems,&nbsp;Inc.</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted W. Love, M.D.</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chair of Board of Directors, Biotechnology Innovation Organization</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harish Manwani</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior Operating Partner, Blackstone; Retired Chief Operating Officer, Unilever</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Javier J. Rodriguez</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mexico</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer, DaVita,&nbsp;Inc.</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony Welters</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lead Independent Director; Chairman and Chief Executive Officer, CINQ Care; Retired Senior Advisor to the Office of CEO, UnitedHealth Group</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew D. Dickinson</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Johanna Mercier</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Commercial Officer</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dietmar Berger, M.D., Ph.D.</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Medical Officer</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deborah H. Telman</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President of Corporate Affairs and General Counsel</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-top: Black 1pt solid; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The present principal occupation for each of these individuals is officer of Gilead Sciences,&nbsp;Inc. and officer, trustee and/or director of other affiliated entities.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Directors and Executive Officers of A1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All addresses are c/o Gilead Therapeutics A1 Unlimited Company,&nbsp;IDA
Business&nbsp;&amp; Technology Park, Carrigtohill, Cork,&nbsp;Ireland T45 DP77.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Citizenship</B></FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; width: 21%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal Occupation</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Cadogan</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ireland</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aoife Marrinan</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ireland</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-top: Black 1pt solid; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The present principal occupation for each of these individuals is employee of Gilead Sciences,&nbsp;Inc. or its affiliated entities and officer, trustee and/or director of other affiliated entities.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>3
<FILENAME>tm252810d1_ex99-4.htm
<DESCRIPTION>EXHIBIT 99.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.4</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0"><B>CERTAIN CONFIDENTIAL INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND REPLACED WITH &ldquo;[&hellip;***&hellip;]&rdquo;
BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SEPARATION AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">dated</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>7 January&nbsp;2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">by and between</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>GALAPAGOS NV</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>GILEAD THERAPEUTICS A1 UNLIMITED COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Investor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>GILEAD SCIENCES INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Parent Investor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Table
of contents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 95%"><FONT STYLE="font-size: 10pt"><B>Articles</B></FONT></TD>
  <TD STYLE="text-align: center; width: 5%"><FONT STYLE="font-size: 10pt"><B>Page</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions and Construction</FONT></TD>
    <TD STYLE="text-align: right; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specific Provisions regarding Potential Acquisitions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restructuring</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specific Provisions regarding SpinCo</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specific Provisions regarding the Company</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specific Covenants of the Investor and Parent Investor</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transitional Services</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adherence by SpinCo</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Intellectual Property</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible Loan by SpinCo to the Company</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further Assurance</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidentiality and Announcements</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governing Law and Dispute Resolution</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 95%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedules</B></FONT></TD>
    <TD STYLE="text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 92%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 1 Separation</FONT></TD>
    <TD STYLE="text-align: right; width: 5%">S-<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 2 Principal terms of Backstop Facility Agreement</FONT></TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 3 Agreed Form Announcement</FONT></TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 4 Adherence Letter</FONT></TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 5 Agreed Form Royalty Agreement</FONT></TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SEPARATION AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">This Separation Agreement (the &quot;<B>Agreement</B>&quot;)
is entered into on 7 January&nbsp;2025,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BY AND BETWEEN:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Galapagos
                                            nv</B></FONT>, a limited liability company (&quot;<I>naamloze vennootschap&quot; / &quot;soci&eacute;t&eacute;
                                            anonyme</I>&quot;) organised and existing under Belgian law, with registered office at Generaal
                                            De Wittelaan L11 A3, 2800 Mechelen, Belgium, registered with the register of legal entities
                                            (Antwerp) under number 0466.460.429 (the &quot;<B>Company</B>&quot;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Gilead
                                            Therapeutics A1 Unlimited Company</B></FONT>, an unlimited liability company formed under
                                            the laws of Ireland, with registered office at 70 Sir John Rogerson's Quay, Dublin 2,&nbsp;Ireland
                                            (the &quot;<B>Investor</B>&quot;); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Gilead
                                            Sciences,&nbsp;Inc</B></FONT><B>.</B>, a Delaware corporation having its principal place
                                            of business at 333 Lakeside Drive, Foster City, CA, 94404, USA (the &quot;<B>Parent Investor</B>&quot;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The parties listed in (1)&nbsp;to (3)&nbsp;above are each hereinafter
referred to as the &quot;<B>Parties</B>&quot;, and each individually as a &quot;<B>Party</B>&quot;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WHEREAS:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify">The Company, a Belgian limited liability company
                                            listed on the regulated markets of Euronext Brussels and Amsterdam and the NASDAQ Stock Market,
                                            is a clinical-stage biotechnology company specialised in the discovery and development of
                                            innovative medicines for the treatment of auto-immune diseases and cancer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify">The Investor is an indirect wholly-owned Subsidiary
                                            of the Parent Investor, a U.S. corporation listed on the NASDAQ Stock Market and a research-based
                                            biopharmaceutical company focused on the discovery, development, and commercialisation of
                                            innovative medicines.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(C)</TD><TD STYLE="text-align: justify">On 14 July&nbsp;2019, the Company and Parent
                                            Investor entered into an option, license and collaboration agreement pursuant to which the
                                            Company agreed to discover, research, and develop molecules and products, and Parent Investor
                                            was granted an option to participate in the development and commercialisation of molecules
                                            and products, in each case, on the terms and conditions set forth in such agreement (the
                                            &quot;<B>Option, License and Collaboration Agreement</B>&quot; or &quot;<B>OLCA</B>&quot;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(D)</TD><TD STYLE="text-align: justify">Simultaneously with the Option, Licence and
                                            Collaboration Agreement, the Company and the Investor, an Affiliate of the Parent Investor,
                                            entered into a subscription agreement (such agreement, as amended prior to the date of this
                                            Agreement, the &quot;<B>Subscription Agreement</B>&quot;), which provided for the issuance
                                            by the Company of, and the subscription by the Parent Investor for, a number of Company's
                                            Ordinary Shares and Warrants (each as defined in the Subscription Agreement).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(E)</TD><TD STYLE="text-align: justify">Following a review by the Company's business
                                            plan and strategy, and taking into account the terms of the OLCA and Subscription Agreement,
                                            the Company intends to separate a portion of its current cash balance, together with certain
                                            other assets and liabilities as set forth herein, into a new entity referred to herein as
                                            &quot;<B>SpinCo</B>&quot; through a partial demerger in the sense of Article&nbsp;12:8, 1&deg;
                                            of the Belgian Companies and Associations Code (&quot;<I>een met splitsing gelijkgestelde
                                            verrichting</I> / <I>une op&eacute;ration assimil&eacute;e &agrave; la scission</I>&quot;)
                                            as a result of which such cash, assets and liabilities shall be transferred to SpinCo, and
                                            the existing shareholders of the Company shall receive shares in SpinCo in the same proportion
                                            as their respective shareholdings in the Company (such transaction, including the adjustment
                                            of the Warrant, the Subscription Rights, the Belgian Tax Recuperation Mechanism and the RSUs,
                                            as contemplated by Articles 2.3 and 2.4, the &quot;<B>Separation</B>&quot;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(F)</TD><TD STYLE="text-align: justify">The Parties' intention is that (i)&nbsp;SpinCo
                                            will identify and invest to build a pipeline of innovative medicines with robust, demonstrated
                                            proof of concept through one or more transactions; (ii)&nbsp;SpinCo's management team will
                                            bring unique experience in asset identification and company-building across the therapeutic
                                            landscape to accelerate development and bring transformative medicines to patients; and (iii)&nbsp;SpinCo's
                                            initial investment focus will be in oncology, immunology and virology.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(G)</TD><TD STYLE="text-align: justify">Furthermore, prior to the Separation, it is
                                            the intention that the Company shall carry out a restructuring of its existing business with
                                            a view to reduce its cash burn, and to focus its activities on developing and commercializing
                                            innovative cell therapies for the treatment of cancer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(H)</TD><TD STYLE="text-align: justify">The terms of this Agreement and the transactions
                                            contemplated by it have been reviewed by the Board of Directors of the Company (taking into
                                            account the provisions of article 7:97 of the Belgian Companies and Associations Code). The
                                            completion of the Separation, however, is still subject to a number of conditions precedent
                                            as further set out in this Agreement, including a prior approval by an extraordinary general
                                            shareholders' meeting of the Company in accordance with the Belgian Companies and Associations
                                            Code.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(I)</TD><TD STYLE="text-align: justify">The Company and the Parent Investor intend
                                            to announce the Separation and other transactions as contemplated herein on or about the
                                            Agreement Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(J)</TD><TD STYLE="text-align: justify">Therefore, each of the parties enters into
                                            this Agreement in consideration of each of the other parties entering into this Agreement
                                            and accepting the terms, undertakings and covenants contained in it.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IT HAS BEEN AGREED AS FOLLOWS:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>1.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Definitions
                                            and Construction</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.1.</B></TD><TD STYLE="text-align: justify"><B>Defined terms</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Terms and expressions that are not
otherwise defined in this Agreement will have the following meanings, save where the content or context requires otherwise:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Acting in Concert</B>&quot;
means, when used in relation to a person or entity, acting in concert (&quot;<I>in onderling overleg handelende personen / personnes
agissant de concert</I>&quot;) in the sense of Article&nbsp;3, &sect;1, 5&deg; and &sect;2 of the Belgian Act of 1 April&nbsp;2007 regarding
public takeover bids, or Article&nbsp;1, &sect;2, 5&deg; of the Belgian Royal Decree of 27 April&nbsp;2007 regarding public takeover
bids.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Adherence Letter</B>&quot;
means the letter substantially in the agreed form as attached in Schedule 4 or in such other form as may be agreed between the Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Adjusted SpinCo Share Value</B>&quot;
means the product obtained by multiplying (i)&nbsp;the SpinCo Share Value times (ii)&nbsp;the Demerger Ratio.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Affiliate</B>&quot; means,
with respect to a particular person or entity, any person, corporation, partnership, or other entity that controls, is controlled by
or is under common control with such person or entity, for so long as such control exists, regardless of whether such person or entity
is or becomes an Affiliate on or after the Agreement Date; <I>provided</I> that (a)&nbsp;the Company, SpinCo and their respective Subsidiaries
shall not be Affiliates of Parent Investor or Investor; and (b)&nbsp;Parent Investor and Investor shall not be Affiliates of the Company,
SpinCo or their respective Subsidiaries. For the purposes of this definition, the word &quot;control&quot; (including, with correlative
meaning, the terms &quot;controlled by&quot; or &quot;under the common control with&quot;) means the actual power, either directly or
indirectly through one or more intermediaries, to direct or cause the direction of the management and policies of such entity, whether
by the ownership of more than fifty percent (50%) of the voting stock of such entity, or by contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Agreement Date</B>&quot; means
the date on which this Agreement is entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Announcement</B>&quot; means
the public announcement regarding the transactions contemplated by this Agreement, attached hereto a Schedule 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Belgian Companies and Associations
Code</B>&quot; means the Belgian Companies and Associations Code of 23 March&nbsp;2019, as amended from time to time, and the rules&nbsp;and
regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>BiotechCo Ratio</B>&quot;
means the quotient obtained by dividing the Company Share Value by the BiotechCo Share Value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>BiotechCo Share Value</B>&quot;
means the volume weighted average of the trading prices of a share of the Company, as reported on Euronext on the first five consecutive
trading days following the Separation Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Board of Directors</B>&quot;
means, when used with respect to the Company or SpinCo, the board of directors (&quot;<I>raad van bestuur </I>/ <I>conseil d'administration</I>&quot;)
of the Company or SpinCo.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Business Day</B>&quot; means
a day (excluding Saturday and Sunday) on which banks generally are open in Mechelen, Belgium, California, United States and Dublin,&nbsp;Ireland
for the transaction of normal banking business, and excluded the period commencing on 25 December&nbsp;and ending on 1 January&nbsp;(inclusive).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Capital Allocation</B>&quot;
means the capital allocation principles as set out in Part&nbsp;B of Schedule 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Company Share Value</B>&quot;
means the sum of the BiotechCo Share Value and the Adjusted SpinCo Share Value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Confidential Information</B>&quot;
has the meaning given to that term in Article&nbsp;13.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Demerger Ratio</B>&quot; means
the number of shares of SpinCo provided in the Separation in respect of one share of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Director</B>&quot; means,
when used in respect of the Company or SpinCo, a member of the Board of Directors of the Company or SpinCo, as relevant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>EGM</B>&quot; means, when
used in respect of the Company or SpinCo, an extraordinary shareholders' meeting of the Company or SpinCo, as relevant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Equity Security</B>&quot;
means, when used in relation to the Company or SpinCo, (i)&nbsp;any share representing the share capital of the Company or SpinCo, respectively,
and (ii)&nbsp;any other security, financial instrument, certificate and other right (including options, futures, swaps and other derivatives)
issued or, with respect to options, futures, swaps and other derivatives, contracted by Company or SpinCo, respectively, and representing,
being exercisable, convertible or exchangeable into or for, or otherwise providing a right to acquire, directly or indirectly, any of
the Equity Securities referred to in (i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>EU Market Abuse Regulation</B>&quot;
means Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April&nbsp;2014 on market abuse (market abuse regulation)
and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and
2004/72/EC, as amended from time to time, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>First Equity
Financing</B>&quot; means the raising of an aggregate gross amount in cash of at least [&hellip;***&hellip;] in equity by the
Company, provided the raising of equity as a result of an exercise or conversion of the following Equity Securities shall not
qualify as or count towards a First Equity Financing: (i)&nbsp;the Warrants, (ii)&nbsp;Subscription Rights, (iii)&nbsp;the RSUs, or
(iv)&nbsp;any other share based incentive plan of the Company from time to time for one or more members of the personnel of the
Company or its Subsidiaries (as defined by Article&nbsp;1:27 of the Belgian Companies and Associations Code), in each case of
(i)&nbsp;to (iv)&nbsp;as adjusted as contemplated by this Agreement in connection with or pursuant to the Separation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Independent Non-Executive
Director</B>&quot; or &quot;<B>INED</B>&quot; means, when used in respect of the Company or SpinCo, an independent non-executive Director
of the Company or SpinCo, as relevant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Option, License and Collaboration
Agreement</B>&quot; or &quot;<B>OLCA</B>&quot; has the meaning given to it in Recital&nbsp;(C).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Novated Agreements</B>&quot;
means the OLCA, the Security Agreement and the Patent Security Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Novation Agreement</B>&quot;
means the novation agreement in the form attached to the Transfer Agreement as Exhibit&nbsp;A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Patent Security Agreement</B>&quot;
means the patent security agreement, dated 23 August&nbsp;2019 by and between the Company and the Parent Investor in connection with
the OLCA, and any other Patent Security Agreements entered into pursuant to the Security Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Quorate EGM</B>&quot; means
an EGM that has been duly and validly convened and meets the requirements, as the case may be, in relation to the attendance quorum for
the shares that are to be present or represented at such EGM in order to allow such EGM to duly and validly deliberate and vote on the
respective proposals and items on the agenda of such EGM in accordance with applicable law and/or the articles of association of the
Company or SpinCo, as relevant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>RSU</B>&quot; means a restricted
stock unit or other form of long term incentive that has been or will be issued, granted or put in place by the Company (or its Subsidiaries)
prior to or after the Agreement Date in accordance with its existing practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Security Agreement</B>&quot;
means the security agreement entered into on 23 August&nbsp;2019 by and between the Company and the Parent Investor in connection with
the OLCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Separation</B> &quot; has
the meaning given to it in Recital (E).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Separation Effective Time</B>&quot;
has the meaning given to it in Article&nbsp;2.5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>SpinCo</B>&quot; means the
company into which the Allocated Assets and Allocated Liabilities of the Company are to be transferred by means of the Separation through
a partial demerger pursuant to the Belgian Companies and Associations Code as contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>SpinCo Initial Capital Allocation</B>&quot;
has the meaning given to that term in Part&nbsp;B of Schedule 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>SpinCo Ratio</B>&quot; means
the quotient obtained by dividing the Company Share Value by the SpinCo Share Value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>SpinCo Share Value</B>&quot;
means the volume weighted average of the trading prices of a share of SpinCo, as reported on Euronext Brussels, on the first five consecutive
trading days following the Separation Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Subscription Agreement</B>&quot;
has the meaning given to it in Recital (D).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Subscription Right</B>&quot;
means any subscription right (&quot;<I>inschrijvingsrecht</I> / <I>droit the souscription&quot;</I>) that has been or will be issued
or granted by the Company for the benefit of one or more members of the personnel of the Company or its Subsidiaries (as defined by Article&nbsp;1:27
of the Belgian Companies and Associations Code) prior to or after the Agreement Date in accordance with its existing practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Subsidiary</B>&quot; means,
when used in relation to an entity (for the purpose of this definition, the &quot;reference entity&quot;), an entity in which the reference
entity directly or indirectly owns, beneficially or of record, (a)&nbsp;an amount of voting securities or other interests in such entity
that is sufficient to enable the reference entity to elect at least a majority of the members of such entity's board of directors or
other governing body, or (b)&nbsp;at least 50% of the outstanding equity or financial interests of such entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Third Party</B>&quot; means
any person or entity other than the Company,&nbsp;Investor,&nbsp;Investor Parent or any of their respective Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Transfer Agreement</B>&quot;
means the transfer agreement entered into on the Agreement Date by and between the Company and the Parent Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Transfer Regulations</B>&quot;
means any law implementing Council Directive 77/187/EEC as amended by Council Directive 98/50EC and any similar legislation in any country
which provides for the automatic transfer of employment in the event of the transfer of a business or services;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&quot;<B>Warrant</B>&quot; means the
subscription right, named &quot;Subsequent Gilead Warrant B&quot;, that has been issued by the Company's extraordinary general shareholders'
meeting held on 30 April&nbsp;2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.2.</B></TD><TD STYLE="text-align: justify"><B>Interpretation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">The titles and headings included in this
                                            Agreement are for convenience only and shall not be taken into account in the interpretation
                                            of the provisions of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">The words &quot;herein&quot;, &quot;hereof&quot;,
                                            &quot;hereunder&quot;, &quot;hereby&quot;, &quot;hereto&quot;, &quot;herewith&quot; and words
                                            of similar import shall refer to this Agreement as a whole and not to any particular Article,
                                            paragraph or other subdivision.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">All periods of time set out in this Agreement
                                            shall be calculated from midnight to midnight local time in Brussels, Belgium. They shall
                                            start on the day following the day on which the event triggering the relevant period of time
                                            has occurred. The expiration date shall be included in the period of time. If the expiration
                                            date is not a Business Day, it shall be postponed until the next Business Day. Unless otherwise
                                            provided herein, all periods of time shall be calculated in calendar days. All periods of
                                            time consisting of a number of months (or years) shall be calculated from the day in the
                                            month (or year) when the triggering event has occurred until the eve of the same day in the
                                            following month(s)&nbsp;(or year(s)) (&quot;<I>van de zoveelste tot de dag v&oacute;&oacute;r
                                            de zoveelste</I>&quot; / &quot;<I>de quanti&egrave;me &agrave; veille de quanti&egrave;me</I>&quot;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(d)</TD><TD STYLE="text-align: justify">References to any statute, regulation
                                            or statutory provision shall be deemed to include reference to any statute, regulation or
                                            statutory instrument which amends, extends, consolidates or replaces the same (or shall have
                                            done so) and to any other regulation, statutory instrument or other subordinate legislation
                                            made thereunder or pursuant thereto, provided that no such reference shall include any amendment,
                                            extension or replacement of the same with retrospective effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(e)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any
                                            reference to a document in the &quot;agreed form&quot; is to the form of the relevant document
                                            in the terms agreed between the Parties before the execution of this Agreement and either
                                            signed or initialled for identification purposes by each of the Parties, or acknowledged
                                            as being in the agreed form in an e-mail sent by each Party (or their solicitors) to each
                                            of the other Parties (or their solicitors) (in each case with any amendments that may be
                                            agreed by or on behalf of the respective Parties).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(f)</TD><TD STYLE="text-align: justify">The original version of this Agreement
                                            has been made in English. Should this Agreement be translated in whole or in part into another
                                            language (if at all), the original English version shall prevail between the Parties hereto
                                            to the fullest extent possible and permitted by Belgian law. Notwithstanding the foregoing,
                                            Belgian legal concepts which are expressed in English language terms, are to be interpreted
                                            in accordance with the Belgian legal terms to which they refer, and the use herein of Dutch
                                            words in this Agreement as translation for certain words or concepts shall be conclusive
                                            in the determination of the relevant legal concept under Belgian law of the words or concepts
                                            that are so translated herein.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">When the words &quot;shall cause&quot;
                                            or &quot;shall procure that&quot; (or any similar expression or any derivation thereof) are
                                            used, the Parties refer to the Belgian legal concept of &quot;<I>sterkmakin</I>g&quot; /
                                            &quot;<I>porte-fort</I>&quot; but this shall also include a guarantee by the relevant party
                                            of the due and timely performance of all actions, agreements and obligations to be performed
                                            by the relevant (third) party under the terms and conditions of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(h)</TD><TD STYLE="text-align: justify">The present Agreement is the outcome of
                                            thorough good faith discussions and negotiations between the Parties, being professional
                                            parties assisted by professional advisors. No Party has relied on, or shall have any right
                                            or remedy in respect of, any statement, representation, assurance, or warranty (whether made
                                            negligently or innocently) other than as expressly set out in this Agreement. Any representations,
                                            promises or conditions not incorporated within this Agreement shall not be binding upon either
                                            Party (without prejudice, for the avoidance of doubt, to other agreements entered into between
                                            the Parties with a subject matter different from the subject matter of this Agreement). The
                                            Parties acknowledge they have each had the opportunity to request the information as provided
                                            in article 5.16 of the Belgian Civil Code, and that the Agreement reflects a fair, equitable
                                            and appropriate balance between their respective rights and obligations as detailed in this
                                            Agreement. To the extent necessary, the Parties acknowledge that they have expressly and
                                            with full understanding of the implications agreed to all of the provisions contained in
                                            this Agreement. In the event of any difficulty of interpretation, the rules&nbsp;set out
                                            in articles 5.64 and 5.65 of the Belgian Civil Code shall apply. The application of article
                                            5.65, 3&deg; and 5.66 of the Belgian Civil Code is expressly waived.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>2.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Separation</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.1.</B></TD><TD STYLE="text-align: justify"><B>Separation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Subject to and in accordance with the
terms and conditions set out in this Agreement and the relevant provisions of the Belgian Companies and Associations Code, the Company
will take the necessary steps in order to allow a Quorate EGM of the Company to approve (the relevant elements of) the Separation through
a partial demerger in accordance with Article&nbsp;12:8, 1&deg; of the Belgian Companies and Associations Code (&quot;<I>een met splitsing
gelijkgestelde verrichting</I> / <I>une op&eacute;ration assimil&eacute;e &agrave; la scission</I>&quot;) (including the adjustment of
the Warrant, the Subscription Rights, the Belgian Tax Recuperation Mechanism and the RSUs, as contemplated by Articles 2.3 and 2.4) and
the grant of rights to the Parent Investor under the Royalty Agreement in accordance with Article&nbsp;7:151 of the Belgian Companies
and Associations Code by undertaking the respective steps set out in Part&nbsp;1 of Schedule 1 (the &quot;<B>Separation Completion Steps</B>&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.2.</B></TD><TD STYLE="text-align: justify"><B>Allocation of Assets and Liabilities
                                            to SpinCo</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">Unless otherwise specified herein, the
                                            assets of the Company to be allocated to SpinCo pursuant to the Separation shall consist
                                            only of the following assets of the Company (the &quot;<B>Allocated Assets</B>&quot;):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(i)</TD><TD STYLE="text-align: justify">an initial cash amount, which at the Separation
                                            Effective Time is to be equal to the amount as determined in accordance with the rules&nbsp;and
                                            principles set out in Part&nbsp;2 of Schedule 1; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(ii)</TD><TD STYLE="text-align: justify">the rights and interests of the Company
                                            in or pursuant to the following agreements of the Company, to the extent that the Company
                                            is a party thereto and/or has any rights or interests in or pursuant to such agreements (the
                                            &quot;<B>Allocated Agreements</B>&quot;):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify">the Subscription Agreement (subject, however,
                                            to the terms and conditions set out in this Agreement); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify">the Novated Agreements (subject, however,
                                            to the terms and conditions set out in the Transfer Agreement and the Novation Agreement);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">provided that the rights and interests
in the Allocated Agreements shall be transferred to SpinCo only to the extent that they relate to any period on or after the Separation
Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Allocated Assets shall also include,
                                            as relevant, the assets of the Subsidiaries of the Company in relation to the matters referred
                                            to in sub-paragraphs (i)&nbsp;to (ii)&nbsp;of paragraph (a)&nbsp;of Article&nbsp;2.2, and
                                            the Company shall cause SpinCo to acquire such Allocated Assets (whether through the process
                                            of the partial demerger in accordance with Article&nbsp;12:8, 1&deg; of the Belgian Companies
                                            and Associations Code (&quot;<I>een met splitsing gelijkgestelde verrichting</I> / <I>une
                                            op&eacute;ration assimil&eacute;e &agrave; la scission</I>&quot;) or otherwise).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">Unless otherwise specified herein, the
                                            liabilities of the Company to be allocated to SpinCo pursuant to the Separation shall consist
                                            only of the following liabilities of the Company (in each case whether such liabilities are
                                            actual, conditional, contingent or otherwise due) (the &quot;<B>Allocated Liabilities</B>&quot;):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(i)</TD><TD STYLE="text-align: justify">the liabilities of the Company in or pursuant
                                            to the Allocated Agreements; <I>provided</I> that such liabilities in or pursuant to the
                                            Allocated Agreements shall be transferred to SpinCo only to the extent that they relate to
                                            any period on or after the Separation Effective Time; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(ii)</TD><TD STYLE="text-align: justify">the liabilities and obligations that
                                            will be allocated to SpinCo pursuant to the adjustment of the Warrant, the Subscription Rights,
                                            the Belgian Tax Recuperation Mechanism and the RSUs as contemplated by Articles 2.3 and 2.4.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(d)</TD><TD STYLE="text-align: justify">The Allocated Liabilities shall also include,
                                            as relevant, the liabilities of the Subsidiaries of the Company in relation to the matters
                                            referred to in sub-paragraphs (i)&nbsp;to (ii)&nbsp;of paragraph (c)&nbsp;of Article&nbsp;2.2,
                                            and the Company shall cause SpinCo to assume such Allocated Liabilities (whether through
                                            the process of the partial demerger in accordance with Article&nbsp;12:8, 1&deg; of the Belgian
                                            Companies and Associations Code (&quot;<I>een met splitsing gelijkgestelde verrichting</I>
                                            / <I>une op&eacute;ration assimil&eacute;e &agrave; la scission</I>&quot;) or otherwise).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(e)</TD><TD STYLE="text-align: justify">Other than the Allocated Assets and Allocated
                                            Liabilities, no other assets and/or liabilities of the Company or its Subsidiaries will be
                                            allocated to SpinCo as part of the Separation, and all of such assets of the Company and
                                            its Subsidiaries (the &quot;<B>Excluded Assets</B>&quot;) and all of such liabilities of
                                            the Company and its Subsidiaries (the &quot;<B>Excluded Liabilities</B>&quot;) will remain
                                            with the Company and its Subsidiaries.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.3.</B></TD><TD STYLE="text-align: justify"><B>Adjustment of the Warrant pursuant
                                            to the Separation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">In connection with the Separation, and
                                            effective as of the Separation Effective Time, the Warrant of the Investor shall be adjusted
                                            pursuant to Article&nbsp;8.3 of the terms and conditions of the Warrant in such a manner
                                            that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(i)</TD><TD STYLE="text-align: justify">the Warrant shall be split into a subscription
                                            right for shares of the Company (the &quot;<B>BiotechCo Warrant</B>&quot;) and a subscription
                                            right for shares of SpinCo (the &quot;<B>SpinCo Warrant</B>&quot;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(ii)</TD><TD STYLE="text-align: justify">the terms and conditions of the BiotechCo
                                            Warrant and SpinCo Warrant shall <I>mutatis mutandis</I> be the same as the terms and conditions
                                            of the Warrant; <I>provided</I> that, from and after the Separation Effective Time:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify">the BiotechCo Warrant entitles the holder
                                            thereof to subscribe, during the entire term of the BiotechCo Warrant, upon each exercise
                                            of the BiotechCo Warrant, for a maximum number of shares of the Company that is, in the aggregate
                                            with respect to each exercise of the BiotechCo Warrant, sufficient to bring the number of
                                            shares of the Company owned by the Investor, the Parent Investor and any of their Affiliates
                                            and any other party Acting in Concert with the Investor, the Parent Investor or any of their
                                            Affiliates to 29.9% of the actually issued and outstanding shares of the Company immediately
                                            after the issue of the shares of the Company that are to be issued upon the relevant exercise
                                            of the BiotechCo Warrant (rounded down to the nearest whole share);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify">the SpinCo Warrant entitles the holder
                                            thereof to subscribe, during the entire term of the SpinCo Warrant, upon each exercise of
                                            the SpinCo Warrant, for a maximum number of shares of SpinCo that is, in the aggregate with
                                            respect to each exercise of the SpinCo Warrant, sufficient to bring the number of shares
                                            of SpinCo owned by the Investor, the Parent Investor and any of their Affiliates and any
                                            other party Acting in Concert with the Investor, the Parent Investor or any of their Affiliates
                                            to 29.9% of the actually issued and outstanding shares of SpinCo immediately after the issue
                                            of the shares of SpinCo that are to be issued upon the relevant exercise of the SpinCo Warrant
                                            (rounded down to the nearest whole share);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(C)</TD><TD STYLE="text-align: justify">the per share exercise price of the BiotechCo
                                            Warrant shall be equal to the quotient (rounded up to the nearest hundredth of a cent) obtained
                                            by dividing (1)&nbsp;the per share exercise price of the Warrant immediately prior to the
                                            Separation Effective Time by (2)&nbsp;the BiotechCo Ratio; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(D)</TD><TD STYLE="text-align: justify">the per share exercise price of the SpinCo
                                            Warrant shall be equal to the quotient (rounded up to the nearest hundredth of a cent) obtained
                                            by dividing (1)&nbsp;the per share exercise price of the Warrant immediately prior to the
                                            Separation Effective Time by (2)&nbsp;the SpinCo Ratio.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">The Company shall cause the preparation
                                            of the necessary reports of the Board of Directors and the statutory auditor of the Company,
                                            and submit the necessary proposals to an EGM of the Company, in order to allow the EGM of
                                            the Company to approve and effect the adjustment of the Warrant, as contemplated by this
                                            Article&nbsp;2.3 in connection with the Separation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">The Company shall cause SpinCo to (i)&nbsp;prepare
                                            the necessary reports of the Board of Directors of SpinCo and the statutory auditor of SpinCo
                                            and (ii)&nbsp;obtain the approval by an EGM of the SpinCo and the effectuation of the adjustment
                                            of the Warrant, as contemplated by this Article&nbsp;2.3 in connection with the Separation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(d)</TD><TD STYLE="text-align: justify">The obligations of SpinCo resulting from
                                            the issuance of the SpinCo Warrant as contemplated by this Article&nbsp;2.3 shall be allocated
                                            to, and assumed by, SpinCo in connection with the Separation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.4.</B></TD><TD STYLE="text-align: justify"><B>Adjustment of the Subscription
                                            Rights and RSUs pursuant to the Separation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">In connection with the Separation, effective
                                            as of the Separation Effective Time:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(i)</TD><TD STYLE="text-align: justify">the Subscription Rights that are outstanding
                                            as of immediately prior to the Separation Effective Time shall be adjusted in accordance
                                            with the applicable terms of such Subscription Rights and in such a manner that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify">each Subscription Right shall be split
                                            into a subscription right for shares of the Company (the &quot;<B>BiotechCo Subscription
                                            Rights</B>&quot;) and a subscription right for shares of SpinCo (the &quot;<B>SpinCo Subscription
                                            Rights</B>&quot;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify">the terms and conditions of the BiotechCo
                                            Subscription Rights and SpinCo Subscription Rights shall <I>mutatis mutandis</I> be the same
                                            as the terms and conditions of the Subscription Rights, subject to what is stated in this
                                            Article&nbsp;2.4; <I>provided</I> that, from and after the Separation Effective Time:</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">the number of shares of the Company subject
                                            to the BiotechCo Subscription Rights shall be equal to the number of shares of the Company
                                            subject to the Subscription Rights immediately prior to the Separation Effective Time;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">the number of shares of SpinCo subject to
                                            the SpinCo Subscription Rights shall be equal to the product (rounded down to the nearest
                                            whole share) obtained by multiplying (1)&nbsp;the number of shares of the Company subject
                                            to the Subscription Rights immediately prior to the Separation Effective Time times (2)&nbsp;the
                                            Demerger Ratio;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(C)</TD><TD STYLE="text-align: justify">the per share exercise price of the BiotechCo
                                            Subscription Rights shall be equal to the quotient (rounded up to the nearest hundredth of
                                            a cent) equal to the quotient obtained by dividing (1)&nbsp;the per share exercise price
                                            of the Subscription Rights immediately prior to the Separation Effective Time by (2)&nbsp;the
                                            BiotechCo Ratio;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(D)</TD><TD STYLE="text-align: justify">the per share exercise price of the SpinCo
                                            Subscription Rights shall be equal to the quotient (rounded up to the nearest hundredth of
                                            a cent) equal to the quotient obtained by dividing (1)&nbsp;the per share exercise price
                                            of the Subscription Rights immediately prior to the Separation Effective Time by (2)&nbsp;the
                                            SpinCo Ratio;&nbsp;and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">each RSU that is outstanding as of immediately
                                            prior to the Separation Effective Time (each, a &quot;<B>Company RSU</B>&quot;) shall be
                                            adjusted in accordance with the applicable terms of such Company RSU and in such a manner
                                            that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify">each Company RSU shall be split into (1)&nbsp;an
                                            RSU that provides for a right or entitlement by reference to shares of the Company (a &quot;<B>BiotechCo
                                            RSU</B>&quot;); and (2)&nbsp;an RSU that provides for a right or entitlement by reference
                                            to shares of SpinCo (a &quot;<B>SpinCo RSU</B>&quot;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify">the terms and conditions of the BiotechCo
                                            RSU and SpinCo RSU shall <I>mutatis mutandis</I> be the same as the terms and conditions
                                            of the Company RSU, subject to what is stated in this Article&nbsp;2.4; <I>provided</I> that,
                                            from and after the Separation Effective Time:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">the number of shares of the Company subject
                                            to the BiotechCo RSU shall be equal to the number of shares of the Company subject to the
                                            Company RSU immediately prior to the Separation Effective Time;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">the number of shares of SpinCo subject to
                                            the SpinCo RSU shall be equal to the product (rounded down to the nearest whole share) obtained
                                            by multiplying (1)&nbsp;the number of shares of the Company subject to the Company RSU immediately
                                            prior to the Separation Effective Time times (2)&nbsp;the Demerger Ratio; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify">the Company shall be able to provide that,
                                            without prejudice to the underlying liabilities being transferred to SpinCo further to the
                                            Separation as of the Separation Effective Time, the Company, instead of SpinCo, shall be
                                            responsible to the holders of the SpinCo RSUs for the payment of cash and/or SpinCo shares
                                            upon the vesting or settlement of the SpinCo RSUs in accordance with the terms of the SpinCo
                                            RSUs (as amended pursuant to this Article&nbsp;2.4) (without the Company being allowed to
                                            deviate from such terms or exercise any discretion in the application of such terms), it
                                            being understood, however, that in such case, in the event of vesting or settlement of such
                                            SpinCo RSUs, SpinCo shall deliver to the Company upon the Company&rsquo;s request, the relevant
                                            amount of cash or (provided that such SpinCo Shares are admitted to trading on Euronext Brussels
                                            or any other market on which such shares would then be admitted to trading or listing) SpinCo
                                            shares payable to such holder upon such vesting or settlement (which such form of payment
                                            shall be at the election of SpinCo, but in any event in accordance with the terms of the
                                            SpinCo RSUs (as amended pursuant to this Article&nbsp;2.4)) (to be increased with any employer
                                            social security effectively paid by the Company in relation to the payment of such SpinCo
                                            RSUs in respect of the period after the Separation Effective Time), such that the relevant
                                            cash or shares can be delivered by the Company to the relevant holders of the SpinCo RSUs.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">The adjustments contemplated by this Article&nbsp;2.4
                                            shall be further elaborated by the Company in accordance with applicable legislation (including
                                            tax and social security rules, and considering standing ruling practice) and regulations,
                                            but taking into account the current terms and conditions of such Subscription Rights and
                                            RSUs. It is understood that any Subscription Right that is exercised, or any RSU that vests
                                            or settles, prior to the Separation Effective Time shall be satisfied and paid by the Company
                                            and shall not be allocated to SpinCo.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">The Company shall, and shall (as relevant)
                                            cause SpinCo to, use its best efforts to make or implement the relevant adjustments as contemplated
                                            by this Article&nbsp;2.4 in relation to (x)&nbsp;the tax financing solution that certain
                                            Belgian Subscription Rights beneficiaries availed themselves of (the &quot;<B>Belgian Tax
                                            Financing Solution</B>&quot;), and (y)&nbsp;the tax recuperation mechanism that was granted
                                            to Belgian Subscription Rights beneficiaries (the &quot;<B>Belgian Tax Recuperation Mechanism</B>&quot;),
                                            provided in any event that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(i)</TD><TD STYLE="text-align: justify">the Belgian Tax Financing Solution and
                                            Belgian Tax Recuperation Mechanism shall be maintained (subject to the relevant adjustments
                                            as contemplated by this Article&nbsp;2.4);&nbsp;and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(ii)</TD><TD STYLE="text-align: justify">the Company shall be able to provide
                                            that, without prejudice to the underlying liabilities being transferred to SpinCo further
                                            to the Separation as of the Separation Effective Time, the Company, instead of SpinCo, shall
                                            be responsible to the holders of the relevant SpinCo Subscription Rights for the payments
                                            under the terms of the Belgian Tax Recuperation Mechanism in relation to the relevant SpinCo
                                            Subscription Rights (without the Company being allowed to deviate from such terms or exercise
                                            any discretion in the application of such terms), it being understood, however, that in such
                                            case, SpinCo shall, and the Company shall cause SpinCo to, pay to the Company the relevant
                                            amounts in cash reflecting the portion of the tax recuperation indemnity that would be due
                                            in relation to any of the relevant SpinCo Subscription Rights (to be increased with any employer
                                            social security effectively paid by the Company in relation to the payment of the relevant
                                            portion of the tax recuperation indemnity in respect of the period after the Separation Effective
                                            Time). It is understood that any tax recuperation indemnity that would be due prior to the
                                            Separation Effective Time will be satisfied and paid by the Company and shall not be allocated
                                            to SpinCo.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(d)</TD><TD STYLE="text-align: justify">The Company shall, and shall (as relevant)
                                            cause SpinCo to, take such steps and obtain such tax rulings as the Company shall deem reasonably
                                            relevant in order to give effect to the adjustment of the Subscription Rights, the Belgian
                                            Tax Recuperation Mechanism and the RSUs, as contemplated by this Article&nbsp;2.4 in connection
                                            with the Separation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">Furthermore, the Company shall cause the
                                            preparation of the necessary reports of the Board of Directors and Statutory Auditor of each
                                            of the Company, and submit the necessary proposals to an EGM of the Company, in order to
                                            allow the EGM of the Company, to approve and effect the adjustment of the Subscription Rights
                                            and RSUs, as contemplated by this Article&nbsp;2.4 in connection with the Separation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(f)</TD><TD STYLE="text-align: justify">The Company shall cause SpinCo to (i)&nbsp;prepare
                                            the necessary reports of the Board of Directors of SpinCo and the statutory auditor of SpinCo
                                            and (ii)&nbsp;obtain the approval by an EGM of the SpinCo and the effectuation of the adjustment
                                            of the Subscription Rights, the Belgian Tax Recuperation Mechanism and the RSUs, as contemplated
                                            by this Article&nbsp;2.4 in connection with the Separation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(g)</TD><TD STYLE="text-align: justify">The obligations of SpinCo resulting from
                                            the adjustment of the Subscription Rights, the Belgian Tax Recuperation Mechanism and the
                                            RSUs, as contemplated by this Article&nbsp;2.4 shall be allocated to, and assumed by, SpinCo
                                            in connection with the Separation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.5.</B></TD><TD STYLE="text-align: justify"><B>Conditions Precedent for Separation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">The Company's obligation pursuant to Article&nbsp;2.1
                                            to effect the Separation in accordance with the terms of this Agreement shall be subject
                                            to the following conditions precedent (&quot;<I>opschortende voorwaarden</I> / <I>conditions
                                            suspensives</I>&quot;) (each a &quot;<B>Condition Precedent</B>&quot; and together, the &quot;<B>Conditions
                                            Precedent</B>&quot;) being satisfied:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(i)</TD><TD STYLE="text-align: justify">the relevant tax ruling(s)&nbsp;(each
                                            a &quot;<B>Tax Ruling</B>&quot;) having been obtained from the Belgian tax administration
                                            with respect to (A)&nbsp;the Separation, confirming the absence of material adverse corporate
                                            income tax consequences as a result of the implementation of the Separation, and (B)&nbsp;the
                                            adjustment of the Subscription Rights pursuant to Article&nbsp;2.4, confirming the tax neutrality
                                            of such adjustments in relation to the Subscription Rights held by holders subject to Belgian
                                            taxation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(ii)</TD><TD STYLE="text-align: justify">the Euronext Brussels Listing having
                                            been obtained in accordance with the terms of Article&nbsp;5.4, subject only to the completion
                                            of the Separation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(iii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">no
                                            action shall have been taken, and </FONT>no statute, rule, regulation or order shall have
                                            been enacted, adopted or issued, by any federal, regional, local or other governmental or
                                            regulatory authority that would prevent the Separation as contemplated by this Agreement,
                                            or render the Separation illegal, and no injunction or order of any federal, regional, local
                                            or other or foreign court shall have been issued that would prevent the Separation as contemplated
                                            by this Agreement, or render the Separation illegal;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(iv)</TD><TD STYLE="text-align: justify">the Company,&nbsp;Investor and Parent
                                            Investor having complied in all material respects with their undertakings and obligations
                                            under this&nbsp;Agreement, the Transfer Agreement and Novation Agreement; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(v)</TD><TD STYLE="text-align: justify">the Separation (including,&nbsp;if required
                                            pursuant to applicable law, the adjustment of the Warrant, the Subscription Rights, the Belgian
                                            Tax Recuperation Mechanism and the RSUs, respectively, pursuant to Articles 2.3 and 2.4,
                                            the appointment of the Independent Non-Executive Directors of SpinCo as contemplated by Article&nbsp;5.7,
                                            and the grant of rights to the Parent Investor under the Royalty Agreement in accordance
                                            with Article&nbsp;7:151 of the Belgian Companies and Associations Code) having been approved
                                            by the EGM of the Company in accordance with the applicable majority and quorum requirements
                                            set out in the Belgian Companies and Associations Code, subject, however, to the provisions
                                            of Article&nbsp;2.5(f)&nbsp;(the &quot;<B>Company EGM Condition</B>&quot;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">Each of the Parties shall co-operate in
                                            good faith and use its best efforts to ensure that each of the Conditions Precedent is satisfied
                                            at the latest by 31 December&nbsp;2025 or such other date as the Parties may agree in writing
                                            (the &quot;<B>Long Stop Date</B>&quot;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">It is intended that the Separation will
                                            be carried out with effect as from the completion of the EGM of the Company that approved
                                            the Separation contemplated by Article&nbsp;2.5(a)(v)&nbsp;(the &quot;<B>Separation Effective
                                            Time</B>&quot;), but for accounting and tax law purposes with retroactive effect as from
                                            1 April&nbsp;2025.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(d)</TD><TD STYLE="text-align: justify">If any Condition Precedent is not satisfied
                                            in accordance with Article&nbsp;2.5(a)&nbsp;or has become impossible to satisfy by the Long
                                            Stop Date, the Parties agree to discuss in good faith any adjustment to the terms of the
                                            Separation in an effort to implement the Separation to the fullest extent possible; <I>provided
                                            </I>that any party shall have the right to terminate this Agreement if the Separation Effective
                                            Time shall not have occurred on or prior to the Long Stop Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(e)</TD><TD STYLE="text-align: justify">The Parties may waive in whole or in part
                                            and conditionally or unconditionally any of the Conditions Precedent by mutual agreement
                                            in writing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(f)</TD><TD STYLE="text-align: justify">With respect to the Condition Precedent
                                            set out in Article&nbsp;2.5(a)(v), if the Separation is not approved by the first Quorate
                                            EGM that has been convened for this purpose, the Parties shall discuss in good faith any
                                            adjustment to the terms of the Separation in an effort to implement the Separation to the
                                            fullest extent possible, and the Company shall convene a subsequent EGM as soon as practicably
                                            possible thereafter in order to obtain the approval of the Separation (with any adjustments
                                            mutually agreed by the Parties) by a subsequent EGM. As the case may be and only where required
                                            by law, any such amendments shall be subject to the application by the Board of Directors
                                            of the Company of the rules&nbsp;and procedures provided for by Article&nbsp;7:97 of the
                                            Belgian Companies and Associations Code.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.6.</B></TD><TD STYLE="text-align: justify"><B>Amendment of Structure and Steps
                                            of the Separation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">The Company shall be entitled to amend
                                            the steps set forth on Part&nbsp;1 of Schedule 1; <I>provided</I> that the Company shall
                                            not be permitted to make any such amendment without the prior written consent of Investor
                                            and Parent Investor if such amendment would be adverse to the Investor, Parent Investor or
                                            any of their Affiliates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">As the case may be and only where required
                                            by law, any such amendments shall be subject to the application by the Board of Directors
                                            of the Company of the rules&nbsp;and procedures provided for by Article&nbsp;7:97 of the
                                            Belgian Companies and Associations Code.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.7.</B></TD><TD STYLE="text-align: justify"><B>Indemnification</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">From and after the Separation Effective
Time:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD>the Company shall release SpinCo from, and indemnify SpinCo for, and
                                            hold SpinCo harmless from, any Excluded Liabilities;&nbsp;and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">SpinCo shall release the Company from,
                                            and indemnify the Company for, and hold the Company harmless from, any Allocated Liabilities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.8.</B></TD><TD STYLE="text-align: justify"><B>Wrong Pockets</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">Excluded Assets or Excluded Liabilities
                                            transferred to SpinCo</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">If the legal title to or the beneficial
interest in any Excluded Asset or Excluded Liability is transferred to or vested in SpinCo, SpinCo shall be deemed to hold such asset
or liability (a &quot;<B>Required Asset or Liability</B>&quot;) on behalf of and for the benefit of the Company, and SpinCo shall, at
the Company's request, as soon as practicable and on terms that no consideration is provided by any person for such transfer:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(i)</TD><TD STYLE="text-align: justify">execute all such deeds or documents as
                                            may be necessary for the purpose of transferring (free of any encumbrance created on or after
                                            Separation) the relevant interest in such Required Asset or Liability to the Company or as
                                            it may direct; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(ii)</TD><TD STYLE="text-align: justify">do or procure to be done all such further
                                            reasonable acts or things and procure the execution of all such other documents as the Company
                                            may reasonably request for the purpose of vesting the relevant interest in such Required
                                            Asset or Liability in the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">Allocated Assets or Allocated Liabilities
                                            remaining with the Company</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">If the legal title to or the beneficial
interest in any Allocated Asset or Allocated Liability, remains vested in the Company after Separation, the Company shall be deemed to
hold such asset or liability (a &quot;<B>Missing Asset or Liability</B>&quot;) on behalf of and for the benefit of SpinCo, and the Company
shall, at SpinCo's request, as soon as practicable and on terms that no consideration is provided by any person for such transfer:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(i)</TD><TD STYLE="text-align: justify">execute all such deeds or documents as
                                            may be necessary for the purpose of transferring (free of any encumbrance created on or after
                                            Separation) the relevant interest in the Missing Asset or Liability to SpinCo or as it may
                                            direct; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(ii)</TD><TD STYLE="text-align: justify">do or procure to be done all such further
                                            reasonable acts or things and procure the execution of all such other documents as SpinCo
                                            may reasonably request for the purpose of vesting the relevant interest in the Missing Asset
                                            or Liability in SpinCo.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">Employees remaining with the Company</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">If any employee of the Company alleges
that it should transfer, or should have transferred, to SpinCo as part of the Separation by way of any Transfer Regulations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(i)</TD><TD STYLE="text-align: justify">the Company or SpinCo, when aware of such
                                            allegation or finding, will promptly notify SpinCo or the Company, respectively, thereof;
                                            and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(ii)</TD><TD STYLE="text-align: justify">SpinCo and the Company will discuss in
                                            good faith how to resolve the issue for a period of 10 Business Days following each of them
                                            becoming aware of the issue pursuant to sub-paragraph (i)&nbsp;above; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(iii)</TD><TD STYLE="text-align: justify">in the absence of agreement between
                                            the Company and SpinCo as to how the issue will be resolved, the Company may take such steps
                                            as it reasonably determines to resolve the issue; <I>provided</I> that no such step shall
                                            involve a transfer of such employee to SpinCo or otherwise involve the imposition of any
                                            cost or liability on SpinCo.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.9.</B></TD><TD STYLE="text-align: justify"><B>Certain Tax Matters</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If the Belgian authorities competent
for VAT would consider, during a VAT audit, that the allocation of any of the Allocated Assets and Allocated Liabilities by the Company
to SpinCo would be subject to Belgian VAT, the Company shall issue to SpinCo a valid VAT invoice, for the Allocated Assets and/or Allocated
Liabilities subject to Belgian VAT, in compliance with the relevant provisions under applicable VAT legislation. SpinCo shall pay the
amount of VAT mentioned on such valid VAT invoice issued by the Company within fifteen (15) business days of receipt of such valid VAT
invoice from the Company and the Parties shall arrange for the necessary calculation, payment and filings under applicable VAT legislation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>3.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Specific
                                            Provisions regarding Potential Acquisitions</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">If the Company desires to acquire rights
                                            to any programs or assets prior to the Separation Effective Time, then the Parties shall
                                            consider in good faith to what extent these should be allocated to SpinCo as part of the
                                            Separation and, if the Parent Investor agrees to make such an allocation, negotiate in good
                                            faith such amendments to this Agreement (including Part&nbsp;2 of Schedule 1) and the OLCA
                                            as shall be required or appropriate in order to accommodate for such acquisition and allocation
                                            to SpinCo.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">Without prejudice to similar provisions
                                            pursuant to the Novation Agreement, after the Separation Effective Time, on a transaction-by-transaction
                                            basis, if SpinCo desires to acquire rights to any programs or assets during the Term (as
                                            defined in the OLCA) of the OLCA (including small molecules, large molecules, cell therapy
                                            or similar, in each case whether through license, merger, acquisition, reorganization, consolidation
                                            or combination or any other transaction), then SpinCo may notify the Parent Investor and
                                            upon receipt of such notice the Parent Investor shall promptly negotiate in good faith with
                                            SpinCo for a period of no less than sixty (60) days an amendment to the OLCA designed to
                                            achieve positive value to SpinCo and all of its shareholders with respect to such programs
                                            and assets, including if needed an amendment to relevant product and program definitions.&nbsp;
                                            Notwithstanding the foregoing, the Parent Investor shall not be required to enter into any
                                            such amendment that is adverse to the Parent Investor or its Affiliates.&nbsp; If such an
                                            amendment is not agreed, then the terms of the OLCA shall continue by its terms.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>4.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Restructuring</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">Prior to the Separation, the Company shall
                                            proceed with the restructuring as set out in the Announcement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">The Parent Investor has waived certain
                                            of its rights and released the Company under the OLCA pursuant to the terms of a letter by
                                            the Parent Investor to the Company, dated on the same day as the Agreement Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>5.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Specific
                                            Provisions regarding SpinCo</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.1.</B></TD><TD STYLE="text-align: justify"><B>Incorporation of SpinCo</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Prior to the Separation, SpinCo will
be incorporated by the Company as a <I>naamloze vennootschap</I> (NV) incorporated under the laws of Belgium, shall have a board of directors
(&quot;<I>raad van bestuur </I>/ <I>conseil d'administration</I>&quot;), and shall be a wholly-owned direct Subsidiary of the Company.
The name of SpinCo shall be further determined by the Company in consultation with the Parent Investor prior to the Separation. It is
the Parties&rsquo; current intention that, as of the Separation Effective Time, SpinCo shall be a Belgian tax resident company, subject
to changes in operational, financial, market, regulatory, or other business conditions that may arise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.2.</B></TD><TD STYLE="text-align: justify"><B>Purpose of SpinCo</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Parties agree that SpinCo will have
the following purpose, which will be reflected in the Separation documentation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">SpinCo will identify and invest to build
                                            a pipeline of innovative medicines with robust, demonstrated proof of concept through one
                                            or more transformative transactions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">SpinCo management will bring unique experience
                                            in asset identification and company-building across the therapeutic landscape to accelerate
                                            development and bring transformative medicines to patients.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">SpinCo's initial investment focus will
                                            be in oncology, immunology and virology.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.3.</B></TD><TD STYLE="text-align: justify"><B>[Reserved]</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.4.</B></TD><TD STYLE="text-align: justify"><B>Listing of SpinCo</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">The Parties intend for all of the shares
                                            of SpinCo be admitted to trading and listing on the regulated market of Euronext Brussels
                                            upon completion of the Separation (the &quot;<B>Euronext Brussels Listing</B>&quot;), and
                                            will use commercially reasonable efforts for the shares of SpinCo to be admitted to trading
                                            and listing on the national market of NASDAQ (through the listing of American Depositary
                                            Shares or &quot;<B>ADSs</B>&quot;) upon completion of the Separation (the &quot;<B>NASDAQ
                                            Listing</B>&quot;); <I>provided</I> that the Parties agree that the NASDAQ Listing shall
                                            not be a condition precedent for the Separation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">SpinCo may also pursue the admission to
                                            trading or listing of the shares of SpinCo upon or following the completion of the Separation
                                            on markets other than Euronext Brussels (pursuant to the Brussels Listing) or NASDAQ (pursuant
                                            to the NASDAQ Listing), such as Euronext Amsterdam (such admission to trading and listing,
                                            an &quot;<B>Additional Listing</B>&quot;), provided, however, that (i)&nbsp;any Additional
                                            Listing is deemed appropriate and reasonable by SpinCo to support the liquidity in the shares
                                            of SpinCo after the completion of the Separation, and (ii)&nbsp;the costs and expenses of
                                            such Additional Listing shall be exclusively borne by SpinCo.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">Prior to Separation occurring, the Company
                                            will take, and will cause SpinCo to take, such steps as are reasonably necessary or appropriate
                                            in order to seek to obtain the Euronext Brussels Listing and NASDAQ Listing as contemplated
                                            by this Agreement, including:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(i)</TD><TD STYLE="text-align: justify">causing SpinCo to pass corporate resolutions
                                            by the Board of Directors and the general shareholders' meeting of SpinCo that are necessary
                                            to allow for the Euronext Brussels Listing and NASDAQ Listing;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(ii)</TD><TD STYLE="text-align: justify">preparing and making, and (where applicable)
                                            causing SpinCo to prepare or make, a listing prospectus, such forms and disclosures (the
                                            &quot;<B>Listing Documentation</B>&quot;), and such filings with the FSMA, Euronext, NASDAQ,
                                            the U.S. Securities and Exchange Commission (&quot;<B>SEC</B>&quot;) and other competent
                                            listing, regulatory or governmental authority (the &quot;<B>Listing Filings</B>&quot;) as
                                            shall be required pursuant to applicable laws and regulations in order to obtain the Euronext
                                            Brussels Listing and NASDAQ Listing; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(iii)</TD><TD STYLE="text-align: justify">entering, or (where applicable) causing
                                            SpinCo to enter, into such agreements and other practical arrangements, including with listing
                                            agent(s), depositaries, and other third parties that are necessary or reasonably customary
                                            for the purposes of the actual admission to listing and trading of the shares and ADSs of
                                            SpinCo pursuant to the Euronext Brussels Listing and NASDAQ Listing, respectively.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.5.</B></TD><TD STYLE="text-align: justify"><B>Governance</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The articles of association and the
corporate governance charter of SpinCo as at the Separation Effective Time shall, <I>mutatis mutandis</I>, be similar to the articles
of association and the corporate governance charter of the Company at the date hereof, subject to the provisions of this Agreement, and
subject to such changes as shall be made by the competent corporate bodies of SpinCo after the Separation Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.6.</B></TD><TD STYLE="text-align: justify"><B>Executive Management of SpinCo</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">It is agreed by the Parties that at the
                                            Separation Effective Time, it is intended that the executive management of SpinCo will consist
                                            of between 3 to 4 persons, that shall be engaged by SpinCo on a full-time basis and which
                                            shall be comprised of biotech executives with significant transaction and company-building
                                            experience (the &quot;<B>SpinCo Management</B>&quot;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">The SpinCo Management will be appointed
                                            by the Company prior to the Separation Effective Time in agreement with the Parent Investor,
                                            based on candidates proposed by the Parent Investor.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.7.</B></TD><TD STYLE="text-align: justify"><B>Board of Directors of SpinCo</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">It is agreed by the Parties that at the
                                            Separation Effective Time, the Board of Directors of SpinCo will consist of a majority of
                                            Independent Non-Executive Directors, and that Investor will have the right to nominate two
                                            (2)&nbsp;Directors in accordance with the Subscription Agreement, as amended pursuant to
                                            Article&nbsp;5.9.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">The Directors and composition of the Board
                                            of Directors of SpinCo will be identified, selected and/or recruited, as the case may be,
                                            by the Company prior to the Separation in agreement with the Parent Investor. The Parent
                                            Investor will, acting in good faith, consult with the Company on the selection process, including
                                            making suggestions as to appointees where appropriate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">The selection of Directors and composition
                                            of the Board of Directors of SpinCo shall need to comply with all applicable Belgian, European
                                            and U.S. legal and regulatory requirements, including any applicable securities regulations
                                            and listing requirements in connection with the Euronext Brussels Listing and, if a NASDAQ
                                            Listing or Additional Listing is obtained, the NASDAQ Listing and any Additional Listing,
                                            as the case may be.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(d)</TD><TD STYLE="text-align: justify">A Director can only qualify as INED if
                                            such director complies with the relevant independence criteria as set out by the Belgian
                                            Companies and Associations Code and rules&nbsp;and regulations of NASDAQ and the U.S. law,
                                            respectively.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(e)</TD><TD STYLE="text-align: justify">The chair of the SpinCo Board of Directors
                                            shall be an Independent Non-Executive Director. If the SpinCo Chief Executive Officer is
                                            appointed as chair of the SpinCo Board of Directors, then another Independent Non-Executive
                                            Director will be selected as the lead Independent Non-Executive Director (the &quot;<B>Lead
                                            INED</B>&quot;). The powers, functions and responsibilities of the Lead INED shall be equivalent
                                            to those that are set out for the Lead INED of the Company in the Corporate Governance Charter
                                            of the Company as at the date hereof, unless determined otherwise by the Board of Directors
                                            of SpinCo.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.8.</B></TD><TD STYLE="text-align: justify"><B>Novated Agreements</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">Subject to the completion of the Separation,
                                            the Novated Agreements shall apply to SpinCo and its programs in accordance with the relevant
                                            terms of the Transfer Agreement and the Novation Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">On the Agreement Date, the Parent Investor
                                            and the Company shall concurrently enter into the Transfer Agreement. The Parent Investor
                                            agrees that it shall enter into the Novation Agreement with the Company and SpinCo as contemplated
                                            by the Transfer Agreement on or about the Agreement Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.9.</B></TD><TD STYLE="text-align: justify"><B>Subscription Agreement and Lock-up
                                            in Relation to the SpinCo</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">Subject to the completion of the Separation,
                                            the Subscription Agreement will be assigned (&quot;<I>overdracht van contract</I> / <I>cession
                                            de contrat</I>&quot;) by the Company to SpinCo, and the obligations of the Company set forth
                                            in the Subscription Agreement will apply to SpinCo, <I>mutatis mutandis</I> as if it was
                                            the Issuer (as defined in the Subscription Agreement), effective as of the Separation Effective
                                            Time, except, however, as set out in this Article&nbsp;5.9, and provided that the rights
                                            and interests and the liabilities in or pursuant to the Subscription Agreement shall be transferred
                                            to SpinCo only to the extent that they relate to any period after the Separation Effective
                                            Time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">Effective as of the Separation Effective
                                            Time, the standstill provision set forth in Article&nbsp;6.1 of the Subscription Agreement
                                            will apply after the Separation between SpinCo and the Investor, but will be amended such
                                            that (i)&nbsp;the Standstill Period (as defined in Article&nbsp;6.1.1 of the Subscription
                                            Agreement) will commence on the date of completion of the Separation and end on the date
                                            that is two (2)&nbsp;years following the date of completion of the Separation, and (ii)&nbsp;(in
                                            addition to Article&nbsp;6.1.1) only clauses (i), (iii)&nbsp;and (v)(a)&nbsp;of Article&nbsp;6.1.2
                                            of the Subscription Agreement and Articles 6.1.3 to 6.1.5 of the Subscription Agreement will
                                            continue to apply.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">Effective as of the Separation Effective
                                            Time, the lock-up provision set forth in Article&nbsp;6.2 of the Subscription Agreement will
                                            apply after the Separation between SpinCo and the Investor, but will be amended so that the
                                            Lock-up Period (and the restrictions applicable during such period of time) will commence
                                            on the date of completion of the Separation and end on the date that is six (6)&nbsp;months
                                            following the date of completion of the Separation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(d)</TD><TD STYLE="text-align: justify">Notwithstanding anything to the contrary
                                            in this Agreement, and for the avoidance of doubt, the following provisions of the Subscription
                                            Agreement will apply after the Separation between SpinCo and the Investor:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(i)</TD><TD STYLE="text-align: justify">the transfer/sale restrictions set forth
                                            in Articles 6.2.2 to 6.2.4 of the Subscription Agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(ii)</TD><TD STYLE="text-align: justify">the registration rights in favour of
                                            the Investor as set forth in Article&nbsp;7.1 of the Subscription Agreement (covering all
                                            shares of SpinCo held by the Investor immediately after the Separation Effective Time), as
                                            modified as necessary to provide the Investor with customary registration rights covering
                                            such shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(iii)</TD><TD STYLE="text-align: justify">the information and remedy provisions
                                            as set forth in Article&nbsp;6.4 of the Subscription Agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(iv)</TD><TD STYLE="text-align: justify">the provisions set forth in Articles
                                            7.3.2 to 7.3.4 of the Subscription Agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(v)</TD><TD STYLE="text-align: justify">the provisions set forth in Article&nbsp;9.3
                                            of the Subscription Agreement; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(vi)</TD><TD STYLE="text-align: justify">the anti-dilution protection set forth
                                            in Articles 6.1.6 and 6.3 of the Subscription Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(e)</TD><TD STYLE="text-align: justify">After the Agreement Date and prior to
                                            or concurrently with the Separation Effective Time, the relevant Parties shall execute an
                                            amended and restated Subscription Agreement reflecting the provisions of this Article&nbsp;5.9,
                                            which such amended and restated Subscription Agreement shall become effective as of the Separation
                                            Effective Time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>6.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Specific
                                            Provisions regarding the Company</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.1.</B></TD><TD STYLE="text-align: justify"><B>Governance of the Company</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">The members of the Company's executive
                                            and senior management as at the Agreement Date shall continue in their respective positions
                                            and mandates with the Company and its Subsidiaries after the Agreement Date, and until after
                                            the Separation Effective Time, in accordance with the terms of their engagement and appointment
                                            by the Company, as amended or varied from time to time by the Company in accordance with
                                            applicable contractual and legal terms.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">Effective as of the Separation Effective
                                            Time, the rights of the Investor to appoint any Investor Board Designees (as defined in the
                                            Subscription Agreement) to the Board of Directors of the Company as provided for by the Subscription
                                            Agreement shall terminate and no longer apply. The Investor shall procure that, effective
                                            as from the Separation Effective Time, all of the Investor Board Designees that shall have
                                            been appointed to the Company's Board of Directors at that time shall resign from their director's
                                            mandate and any other powers that shall have been delegated to them by the Board of Directors.
                                            The proposal to interim discharge the Investor Board Designees from liability in connection
                                            with the performance of their mandate during the financial year in which the Separation Effective
                                            Time shall fall, shall be submitted to the general shareholders' meeting of the Company that
                                            will decide on the approval of the Separation. The proposal to final discharge the Investor
                                            Board Designees from liability in connection with the performance of their mandate during
                                            the financial year in which the Separation Effective Time shall fall, shall be submitted
                                            to the general shareholders' meeting of the Company that will decide on the approval of the
                                            statutory (non-consolidated) financial statements for such financial year, in accordance
                                            with applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.2.</B></TD><TD STYLE="text-align: justify"><B>Royalties</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Effective as of the Separation Effective
Time, the Company and the Parent Investor shall enter into the royalty agreement in the agreed form as attached in Schedule 5 (&quot;<B>Royalty
Agreement</B>&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.3.</B></TD><TD STYLE="text-align: justify"><B>Termination of Subscription Agreement
                                            in Relation to the Company</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Subscription Agreement shall continue
in accordance with its terms until the Separation Effective Time. Effective as from the Separation Effective Time, the Subscription Agreement
shall terminate in relation to the Company, and shall no longer apply to the Company, provided that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">such termination shall be without prejudice
                                            to the rights that shall have accrued to the parties to the Subscription Agreement prior
                                            to the Subscription Agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">such termination shall be without prejudice
                                            to the provisions of Article&nbsp;5.9 of this Agreement, which provide for the assignment
                                            of the Subscription Agreement to SpinCo;&nbsp;and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">the provisions of Articles 6.4 to 6.9
                                            of this Agreement shall be without prejudice to similar provisions of the Subscription Agreement,
                                            which shall continue to apply until the Separation Effective Time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.4.</B></TD><TD STYLE="text-align: justify"><B>Standstill in Relation to the Company</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.4.1</TD><TD STYLE="text-align: justify">The standstill obligation, as set out in
                                            this Article&nbsp;6.4, will take effect as of the Separation Effective Time and will terminate
                                            on 22 August&nbsp;2029 (the &quot;<B>Standstill Period</B>&quot;). This shall be without
                                            prejudice to the provisions of the Subscription Agreement which shall continue to apply in
                                            relation to the Company until the Separation Effective Time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.4.2</TD><TD STYLE="text-align: justify">During the Standstill Period, the Investor,
                                            the Parent Investor or any of their Affiliates, shall not:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">without the express written consent of
                                            the Company, directly or indirectly acquire any additional Equity Securities of the Company,
                                            if after giving effect to such acquisition the Investor, the Parent Investor, any of the
                                            Affiliates of the Investor or the Parent Investor, or any other party Acting in Concert with
                                            the Investor, the Parent Investor or any of the Affiliates of the Investor or the Parent
                                            Investor would (without taking into account the Warrant or the shares issuable (but not yet
                                            issued) thereunder owned by them at that time) together in the aggregate directly or indirectly
                                            own or have the right to acquire more than 29.9% of the then issued and outstanding voting
                                            securities of the Company (assuming the exercise, conversion or exchange of any Equity Securities
                                            held by any of them at any time (other than the Warrant) that are exercisable, convertible
                                            or exchangeable into or for shares of the Company at such time) (the resulting number of
                                            securities rounded down) (the &quot;<B>Standstill Limit</B>&quot;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">directly or indirectly encourage or support
                                            a tender, exchange or other offer or proposal by a third party;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">propose (i)&nbsp;any merger, consolidation,
                                            business combination, tender or exchange offer, purchase of the Company's assets or businesses,
                                            or similar transaction involving the Company or (ii)&nbsp;any recapitalization, restructuring,
                                            liquidation or other extraordinary transaction with respect to the Company (it being understood
                                            that the Investor's Chief Executive Officer may contact the Company's Chief Executive Officer
                                            on a non-public and non-committal basis to gauge the Company's Chief Executive Officer's
                                            views on the Company's potential interest in any such matter described in clause (i)&nbsp;or
                                            (ii)); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(d)</TD><TD STYLE="text-align: justify">directly or indirectly (i)&nbsp;submit
                                            matters to, request that matters be submitted to, or request the convening of, a general
                                            meeting of the shareholders of the Company, or (ii)&nbsp;solicit proxies or consents, or
                                            become a participant in a solicitation in relation to matters submitted to a general meeting
                                            of the shareholders of the Company, in each case of (i)&nbsp;and (ii)&nbsp;without or against
                                            the recommendation or support by the Board of Directors of the Company except that Investor
                                            may solicit proxies or consents and may become a participant in a solicitation in connection
                                            with any proposal that would adversely affect its rights under this Agreement, the Warrant,
                                            the Royalty Agreement or as a shareholder of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(e)</TD><TD STYLE="text-align: justify">(i)&nbsp;make public statements with respect
                                            to (save if legally obliged to) or, (ii)&nbsp;with the actual knowledge of the Parent Investor's
                                            executive officers, provide assistance to, commit to, or discuss or enter into any agreement
                                            or arrangement with any party to do, any of the foregoing prohibited actions provided that
                                            in relation to prohibited actions in subsection (b)&nbsp;that have been committed without
                                            the actual knowledge of the Parent Investor's executive officers, the Investor and Parent
                                            Investor shall promptly terminate and unwind such actions upon written request of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(Article&nbsp;6.4.2 (a)&nbsp;through (e)&nbsp;together,
the &quot;<B>Standstill</B>&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.4.3</TD><TD STYLE="text-align: justify">In the event that (a)&nbsp;the Company has
                                            received a non-public binding or non-binding offer, prior to the end of the Standstill Period,
                                            by a bona fide third party, other than the Investor, the Parent Investor, any of the Affiliates
                                            of the Investor or the Parent Investor, or any other party Acting in Concert with the Investor,
                                            the Parent Investor or any of the Affiliates of the Investor or the Parent Investor, regarding
                                            a bona fide potential takeover bid on the Company (including any tender, exchange or other
                                            offer or proposal to acquire a majority of the outstanding equity securities of the Company
                                            or all or a substantial part of its consolidated assets), and such offer is publicly supported
                                            or recommended by the Board of Directors, (b)&nbsp;the Company determines to commence, prior
                                            to the end of the Standstill Period, a process to seek a potential sale of the Company or
                                            all or a substantial part of its consolidated assets, (c)&nbsp;a bid other than from the
                                            Investor, the Parent Investor, any of the Affiliates of the Investor or the Parent Investor,
                                            or any other party Acting in Concert with the Investor, the Parent Investor or any Affiliates
                                            of the Investor of the Parent Investor, is announced to take over the Company pursuant to
                                            article 7 or 8, &sect;1, &sect;2 and &sect;3 of the Belgian Royal Decree of 27 April&nbsp;2007
                                            on public takeover bids, or (d)&nbsp;any bona fide person or entity (other than the Investor,
                                            the Parent Investor, any of the Affiliates of the Investor or the Parent Investor, or any
                                            other party Acting in Concert with the Investor, the Parent Investor or any of the Affiliates
                                            of the Investor or the Parent Investor) publicly discloses any plans, determined as serious
                                            by the Board of Directors to further pursue it, to make such a bid, then the Standstill obligations
                                            shall automatically cease to apply effective upon the occurrence of such approach, process,
                                            announcement or public disclosure (the &quot;<B>Lift of the Standstill</B>&quot;) and the
                                            Company shall notify the Investor of such offer, process or announcement as promptly as practicable
                                            and in any event no later than one (1)&nbsp;Business Day after such offer, process or announcement
                                            (the &quot;<B>Lift of Standstill Notification</B>&quot;). Upon the Lift of the Standstill,
                                            the Standstill obligation of the Investor shall be lifted in order to level the playing field
                                            and grant it equal opportunities to prepare a takeover bid or take other permitted actions,
                                            such that the Investor shall not in any respect be disadvantaged or limited relative to any
                                            other bidder for the Company. It being understood and agreed by the Investor that the Company
                                            shall not be required to specify in the Lift of Standstill Notification the identity of any
                                            involved third party or any other specifics of the terms of such proposed transaction.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.4.4</TD><TD STYLE="text-align: justify">The Investor explicitly acknowledges that
                                            the information contained in the Lift of Standstill Notification may, prior to the public
                                            announcement of such information, constitute material, non-public information of the Company
                                            and inside information within the meaning of the EU Market Abuse Regulation. When receiving
                                            the Lift of Standstill Notification, the Investor shall&nbsp;take all appropriate measures
                                            to ensure the confidentiality of such information.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.4.5</TD><TD STYLE="text-align: justify">It is expressly acknowledged by the Parties
                                            that the Company may not be in a position to notify the Investor of a takeover bid beforehand,
                                            such as for example in the event of a non-solicited takeover bid immediately filed with the
                                            Financial Services and Markets Authority (the &quot;<B>FSMA</B>&quot;) without prior approach.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.4.6</TD><TD STYLE="text-align: justify">For the avoidance of doubt, during the Standstill
                                            Period, the Investor and its Affiliates may acquire, including on the open market or in privately
                                            negotiated purchases, any additional Equity Securities of the Company, but only up to the
                                            Standstill Limit.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.5.</B></TD><TD STYLE="text-align: justify"><B>Lock-up in Relation to the Company</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.5.1</TD><TD STYLE="text-align: justify">During the period running from the Agreement
                                            Date through the earliest to occur of (x)&nbsp;the termination of this Agreement, the Conditions
                                            Precedent not being satisfied at the latest by the Long Stop Date or the Separation having
                                            not occurred by the Long-Stop Date, (y)&nbsp;the date that is six (6)&nbsp;months following
                                            the date on which the First Equity Financing has been completed by the Company, and (z)&nbsp;31
                                            March&nbsp;2027 (the &quot;<B>Lock-up Period</B>&quot;), the Investor and Parent Investor
                                            shall not, and shall cause their Affiliates not to, without the prior consent of the Company,
                                            transfer, sell or otherwise dispose of any Equity Securities issued by or of the Company
                                            held by the Investor, the Parent Investor and their Affiliates, as applicable, (other than
                                            transfers, sales or dispositions permitted pursuant to Article&nbsp;6.5.4); provided, however,
                                            that the Lock-up Period shall automatically terminate in the event that (a)&nbsp;the Company
                                            has received a non-public offer, prior to the end of the Lock-up Period, by a bona fide third
                                            party, other than the Investor, the Parent Investor, any of the Affiliates of the Investor
                                            or the Parent Investor, or any other party Acting in Concert with the Investor, the Parent
                                            Investor or any of the Affiliates of the Investor or the Parent Investor, regarding a bona
                                            fide potential takeover bid on the Company (including any tender, exchange or other offer
                                            or proposal to acquire a majority of the outstanding shares of the Company or all or a substantial
                                            part of its consolidated assets (except, until the Separation Effective Time, where the disposal
                                            of such substantial part of its assets would not adversely affect the Company's ability to
                                            comply with its obligations under the OLCA in any material respect), and such offer is publicly
                                            supported or recommended by the Board of Directors of the Company, (b)&nbsp;the Company determines
                                            to commence, prior to the end of the Lock-Up Period, a process to seek a potential sale of
                                            the Company or all or a substantial part of its consolidated assets (except, until the Separation
                                            Effective Time, where the disposal of such substantial part of its assets would not adversely
                                            affect the Company's ability to comply with its obligations under the OLCA in a material
                                            respect), (c)&nbsp;a bid other than from the Investor, the Parent Investor, any of the Affiliates
                                            of the Investor or the Parent Investor, or any other party Acting in Concert with the Investor,
                                            the Parent Investor or any Affiliates of the Investor of the Parent Investor, is announced
                                            to take over the Company pursuant to article 7 or 8, &sect;1, &sect;2 and &sect;3 of the
                                            Belgian Royal Decree of 27 April&nbsp;2007 on public takeover bids, (d)&nbsp;any bona fide
                                            person or entity (other than the Investor, the Parent Investor, any of the Affiliates of
                                            the Investor or the Parent Investor, or any other party Acting in Concert with the Investor,
                                            the Parent Investor or any of the Affiliates of the Investor or the Parent Investor) publicly
                                            discloses any plan, determined as serious by the Board of Directors to further pursue it,
                                            to make such a bid, or (e)&nbsp;(x)&nbsp;until the Separation Effective Time, the Company
                                            breaches the OLCA and the OLCA is terminated by the Parent Investor as a result, or (y)&nbsp;after
                                            the Separation Effective Time, the Company breaches the Royalty Agreement and the Royalty
                                            Agreement is terminated by the Parent Investor as a result.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.5.2</TD><TD STYLE="text-align: justify">As from the Separation Effective Time, upon
                                            expiry of the Lock-up Period, the Investor, the Parent Investor and any of their Affiliates
                                            may, after notifying the Company of their intent to do so, transfer, sell or otherwise dispose
                                            of the shares of the Company, taking into account that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify"><U>when instructing a bank to sell the
                                            shares of the Company (other than in a transaction described in subsections&nbsp;(b)&nbsp;through&nbsp;(d)&nbsp;below)
                                            </U>&ndash; the bank shall be instructed to use reasonable efforts to effect such sale of
                                            the shares of the Company in a manner reasonably intended to minimize disturbances of the
                                            share price of the Company, as quoted on Euronext Brussels and Amsterdam or on the NASDAQ
                                            Stock Market;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify"><U>when selling the shares of the Company
                                            on the open market</U> &ndash; the Investor shall be permitted to sell shares of the Company
                                            on the open market at a daily volume not to exceed 20% of the average daily volume of shares
                                            of the Company as traded on the relevant market on which the sale is effected for the previous
                                            thirty (30) trading days, as quoted on Euronext Brussels and Amsterdam;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify"><U>when selling the shares of the Company
                                            through a privately negotiated transaction</U> &ndash; the transaction shall not be subject
                                            to the limitations in this Article&nbsp;6.5.2 if the transaction would not be reported in
                                            Euronext's consolidated tape on the date on which the transaction is agreed by the parties;
                                            or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(d)</TD><TD STYLE="text-align: justify"><U>when selling the shares of the Company
                                            in a &quot;block trade&quot;</U> &ndash; the block trade shall not be subject to the limitations
                                            in this Article&nbsp;6.5.2 if it is the only sale by the Investor on the date of the block
                                            trade.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.5.3</TD><TD STYLE="text-align: justify">As from the Separation Effective Time, after
                                            the expiry of the Lock-up Period, the Company shall, to the extent legally permitted, provide
                                            notice to the Investor as promptly as reasonably practicable in the event that the Company
                                            becomes aware that any person or entity is interested in purchasing or selling shares of
                                            the Company in a &quot;block trade&quot;.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.5.4</TD><TD STYLE="text-align: justify">The following transfers, sales or divestment
                                            of Equity Securities of the Company shall be permitted and not be subject to the restrictions
                                            set out in Article&nbsp;6.5.1:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">any transfer, sale or other divestment
                                            of Equity Securities by the Investor to any of its Affiliates, provided that (i)&nbsp;the
                                            obligations of the Investor, the Parent Investor or any of their Affiliates pursuant to this
                                            Agreement and, if prior to the Separation Effective Time, the Option, License and Collaboration
                                            Agreement remain unaffected by the proposed transfer, sale or divestment, (ii)&nbsp;the transferee
                                            agrees in writing to the Company to be bound by the restrictions set out in Article&nbsp;6.5.1
                                            and 6.5.2 in relation to the Equity Securities it received and the other obligations of the
                                            Investor in relation to the Equity Securities under this Agreement, and (iii)&nbsp;the relevant
                                            Equity Securities will be re-transferred to the Investor or the Parent Investor immediately
                                            prior to the transferee ceasing to be an Affiliate of the Investor or the Parent Investor;
                                            and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">any transfer pursuant to a stock lending
                                            that is agreed to by the parties to facilitate the cashless exercise of stock based incentive
                                            plans that have been put in place for employees, officers, directors or consultants of the
                                            Company or its Subsidiaries, provided that upon expiry of the stock lending and the re-transfer
                                            of the relevant shares of the Company to the Investor, such shares are again subject to the
                                            restrictions set out in Article&nbsp;6.5.1 and 6.5.2 for the remainder of the term.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.6.</B></TD><TD STYLE="text-align: justify"><B>Remedy</B></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In the event of a material breach of the provisions of Articles 6.4 (other than Article 6.4.4) or 6.5 by the Investor (provided that a
breach of the notice requirements of Article 6.5.2 shall not constitute a material breach), the Parent Investor or any of their Affiliates
and, provided that such breach can be cured, such breach is not cured within five (5) Business Days after such breach has been notified
in writing to the Investor, the following rights of the Investor shall be suspended until such breach has been cured:</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 36pt">&nbsp;</TD>
  <TD STYLE="width: 34.9pt">(a) </TD>
  <TD>the rights of the Investor pursuant to Articles 6.7 (other than pursuant to Article 6.7(b)); and</TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 36pt">&nbsp;</TD>
  <TD STYLE="width: 34.9pt">(b)</TD>
  <TD>the right to exercise the Warrant.</TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Split-Segment; Name: a2 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.7.</B></TD><TD STYLE="text-align: justify"><B>Specific Covenants of the Company</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">To the extent legally required, the Company
                                            shall prepare a listing prospectus and shall use reasonable efforts to obtain a listing on
                                            the regulated markets of Euronext Brussels and Amsterdam for the shares in the Company held
                                            by the Investor as at the Separation Effective Time, within ninety (90)&nbsp;days following
                                            the Closing. In such case, the effective listing will be subject to regulatory approval of
                                            the listing prospectus. To the extent that a listing prospectus is not legally required to
                                            obtain a listing on the regulated markets of Euronext Brussels and Amsterdam for the aforementioned
                                            shares, the Company shall cause the listing of such shares as soon as practicable after the
                                            Separation Effective Time, and in any event no later than five (5)&nbsp;Business Days after
                                            the Separation Effective Time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">During the Standstill Period and during
                                            any period that the Company and the Investor, the Parent Investor, or any of the Affiliates
                                            of the Investor or the Parent Investor were to be affiliates or intermediaries of each other
                                            (within the meaning of the Belgian Royal Decree of 27 April&nbsp;2007 on public takeover
                                            bids) or were to Act in Concert, the Company shall not, without the express written consent
                                            of the Investor, directly or indirectly (including through affiliates or intermediaries within
                                            the meaning of the Belgian Royal Decree of 27 April&nbsp;2007 on public takeover bids or
                                            parties Acting in Concert with the Company or such affiliates or intermediaries) acquire
                                            any voting securities of the Company, or take any other action, if after giving effect to
                                            such acquisition or the taking of such other action the Investor, the Parent Investor, or
                                            any of the Affiliates of the Investor or the Parent Investor, would directly or indirectly
                                            (including through affiliates or intermediaries within the meaning of the Belgian Royal Decree
                                            of 27 April&nbsp;2007 on takeover bids or any other party Acting in Concert with the Investor
                                            or such affiliates or intermediaries) own, or were to continue to own, more than 29.9% of
                                            the then issued and outstanding voting securities of the Company on a non-diluted basis (the
                                            resulting number of securities rounded down) or would otherwise oblige the Investor, the
                                            Parent Investor, or any of the Affiliates of the Investor or the Parent Investor, to launch
                                            a public takeover bid on securities of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">From and after the date hereof until the
                                            date that the Investor, together with its Affiliates, no longer owns 10% or more of the outstanding
                                            shares of the Company, the Company shall, upon reasonable notice by the Investor, provide
                                            access (for not more often than once per calendar year) to the Investor to its financial
                                            books to facilitate compliance with the Investor's accounting or financial reporting requirements.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.8.</B></TD><TD STYLE="text-align: justify"><B>Conduct of Business by the Company</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">Nothing in this Agreement shall restrict
                                            or prevent the Company from considering and proceeding with any business combination, divestment,
                                            acquisition, financing, licensing or other business or commercial transaction (whether in
                                            whole or in part), (i)&nbsp;except until the Separation Effective Time, as agreed in relation
                                            to or pursuant to the Option, License and Collaboration Agreement (as amended from time to
                                            time) and (ii)&nbsp;unless such action would (A)&nbsp;reasonably be expected to impair or
                                            delay the Separation or the other transactions contemplated by this Agreement in any material
                                            respect or (B)&nbsp;have as a primary purpose to impair or be adverse to the rights of Investor
                                            or Investor Parent under this Agreement or the other agreements contemplated to be executed
                                            by Investor or Investor Parent, including the Royalty Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">Prior to the Separation, the Company may
                                            commence with any third-party partnership and financing discussions with respect to Company's
                                            business, assets and its programs that is not allocated to SpinCo in connection with the
                                            Separation, provided, however, that any such partnerships or financing transactions do not
                                            take effect until after the Separation Effective Time, unless otherwise agreed to by the
                                            Parent Investor.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Options: NewSection; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.9.</B></TD><TD STYLE="text-align: justify"><B>Taxes</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The provisions of this Article&nbsp;6.9
apply as from the Separation Effective Time:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.9.1</TD><TD STYLE="text-align: justify">US Federal Income Tax Information Reporting</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">For each taxable year in which Investor
                                            holds shares of Company, Company shall determine whether Company or any of Company's Subsidiaries
                                            was a &quot;passive foreign investment company,&quot; as defined in section 1297(a)&nbsp;of
                                            the U.S. Internal Revenue Code (a &quot;<B>PFIC</B>&quot;) for such taxable year and, if
                                            Company determines that Company or any of Company's Subsidiaries was a PFIC for such taxable
                                            year, (i)&nbsp;Company shall, no later than thirty (30) days from the date of the close of
                                            Company's taxable year, notify Investor of such determination and (ii)&nbsp;Company shall
                                            provide Investor with adequate information in Company's possession (at Investor's expense)
                                            in order for Parent Investor, in consultation with Investor and Company, to complete its
                                            U.S. Internal Revenue Service Form&nbsp;8621 with respect to Company or such Subsidiary;
                                            provided that if Parent Investor intends to elect to treat Company and/or any Subsidiary
                                            as a &quot;qualified electing fund,&quot; as defined in section 1295 of the U.S. Internal
                                            Revenue Code,&nbsp;Investor shall notify Company of such intent, and Company shall provide
                                            Investor (at Investor's expense) with PFIC Annual Information Statements.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">For each taxable year in which Investor
                                            holds shares of Company,&nbsp;Investor shall determine whether Company or any of Company's
                                            Subsidiaries is a &quot;controlled foreign corporation,&quot; within the meaning of as defined
                                            in section 957 of the U.S. Internal Revenue Code (a &quot;<B>CFC</B>&quot;) for such taxable
                                            year with respect to Parent Investor and, if Investor determines that Company or any of Company's
                                            Subsidiaries was a CFC for such taxable year with respect to Parent Investor, (i)&nbsp;the
                                            Company shall, no later than thirty (30) days from the close of Company's taxable year, notify
                                            Company of such determination and (ii)&nbsp;the Company shall provide Investor with adequate
                                            information in Company's possession (at Investor's expense) in order for Investor, in consultation
                                            with Company, to reasonably determine any amounts required to be included pursuant to sections
                                            951(a)&nbsp;and 951A of the U.S. Internal Revenue Code in the gross income of Parent Investor
                                            as defined in section 951(b)&nbsp;of the U.S. Internal Revenue Code and to comply with Parent
                                            Investor's filing obligations under the U.S. Internal Revenue Code, including, but not limited
                                            to, completing the U.S. Internal Revenue Service Form&nbsp;5471 with respect to Company or
                                            any such Subsidiaries, all of such information to be issued in an annual statement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.9.2</TD><TD STYLE="text-align: justify">The Parties agree to reasonably cooperate
                                            with one another and use reasonable efforts to mitigate or reduce tax withholding or similar
                                            obligations in respect of payments made by Investor to Company under this Agreement (as the
                                            case may be) where an exemption or reduction of such withholding or similar obligation is
                                            available under the applicable legislation, including double tax treaties.&nbsp;Without limiting
                                            the generality of the foregoing, Company shall provide Investor at Investor's expense any
                                            tax forms and other information in Company's possession that may be reasonably requested
                                            by Parent Investor in order for it to prepare its U.S. tax filings. Each Party shall provide
                                            the other with reasonable assistance to enable the recovery, as permitted by Applicable Law
                                            (as defined in the Option, License and Collaboration Agreement), of withholding taxes, value
                                            added taxes, or similar obligations resulting from payments made under this Agreement, such
                                            recovery to be for the benefit of the Party bearing such withholding tax or value added tax.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.9.3</TD><TD STYLE="text-align: justify">Except as would have an adverse effect on
                                            Company or any of Company's Subsidiaries and subject to the sole consent of Company, such
                                            consent not to be unreasonably withheld, Company agrees to reasonably cooperate with Investor
                                            and use reasonable efforts (i)&nbsp;to provide Investor with such information as is reasonably
                                            requested by Investor to permit Investor to make the determinations under Section&nbsp;6.9.1(b)&nbsp;of
                                            this Agreement, and (ii)&nbsp;to avoid or reduce any amounts required to be included pursuant
                                            to sections 951(a)&nbsp;and 951A of the U.S. Internal Revenue Code in the gross income of
                                            any &quot;United States shareholder&quot;, as defined in section 951(b)&nbsp;of the U.S.
                                            Internal Revenue Code, including, without limitation, by filing any elections reasonably
                                            requested by Investor under U.S. Treasury Regulations section 301.7701-3 with respect to
                                            any Subsidiary.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>7.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Specific
                                            Covenants of the Investor and Parent Investor</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">The Investor irrevocably confirms to the
                                            Company that it will, and the Parent Investor irrevocably confirms to the Company that it
                                            will cause the Investor to, exercise its rights as a shareholder in the Company to attend
                                            any EGM of the Company to which proposals in relation to the Separation shall be submitted,
                                            and if such EGM is a Quorate EGM, to vote with all of its shares in order to approve the
                                            Separation and any other related matters, in each case if such Separation is in accordance
                                            with the terms of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">From and after the Agreement Date, but
                                            without limiting the rights of any Party under this Agreement, the Parties hereby waive,
                                            on behalf of themselves and their Affiliates, to the fullest extent permitted by applicable
                                            Law, any and all other rights, claims and causes of action (including rights of contribution,
                                            if any) known or unknown, foreseen or unforeseen, which exist or may arise in the future,
                                            that they may have against each other, their Affiliates or (direct or indirect) agents or
                                            representatives, as a result of or in connection with discussions or negotiations prior to
                                            the Agreement Date of the Separation, whether arising under or based upon breach of contract
                                            (including for breach of any representation, warranty, covenant or agreement), warranty,
                                            tortious conduct (including negligence), under law or otherwise and whether predicated on
                                            common law, statute, strict liability, or otherwise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">From and after the Separation Effective
                                            Time, SpinCo shall, to the greatest extent permitted by law, indemnify each former or current
                                            (as of the completion of the Separation) INED, executive Director, and Officer and member
                                            of the executive management of the Company (each an &quot;<B>Indemnified Party</B>&quot;)
                                            for, and hold each Indemnified Party harmless from and against, any loss, claim, damage,
                                            liability, cost and expense (including reasonably attorney fees) (each a &quot;<B>Prejudice</B>&quot;)
                                            incurred or paid by any of them as a result of any allegation, claim, dispute or other proceedings
                                            by a Third Party (or any settlement thereof or any defence thereto) (each a &quot;<B>Third
                                            Party Claim</B>&quot;) against such Indemnified Party in which such Indemnified Party may
                                            become involved (whether as a party or otherwise) (whether before or after the Separation
                                            Effective Time) that has arisen in connection with such Indemnified Party's function, position,
                                            mandate or conduct as an INED, executive Director, Officer or member of the executive management
                                            of the Company, in furtherance of the Separation (including such Indemnified Party&rsquo;s
                                            conduct in negotiating and/or approving the Separation or taking any action contemplated
                                            by this Agreement or the Separation), except to the extent it is finally determined by a
                                            court of competent jurisdiction that such Prejudice has arisen (and then only to such extent)
                                            as a result of the Indemnified Party's wilful misconduct or gross negligence, as the case
                                            may be; <I>provided</I> that SpinCo's obligation pursuant to this paragraph (c)&nbsp; in
                                            relation to the Prejudice suffered by such Indemnified Party shall be limited to the full
                                            amount of the Prejudice suffered by Indemnified Party and in relation to which the Indemnified
                                            Party can seek indemnification from SpinCo pursuant to this paragraph (c)&nbsp;multiplied
                                            by a fraction of which (x)&nbsp;the numerator is equal to the Initial SpinCo Capital Allocation
                                            (as determined in accordance with the rules&nbsp;and principles set out in Part&nbsp;2 of
                                            Schedule 1) and (y)&nbsp;the denominator is the sum of the Initial SpinCo Capital Allocation
                                            plus the amount of the cash (as defined in Schedule 1) remaining with the Company immediately
                                            after the Separation Effective Time. Immediately following the Separation Effective Time,
                                            SpinCo shall ratify and reconfirm its undertaking and obligations pursuant to this paragraph
                                            (c).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(d)</TD><TD STYLE="text-align: justify">The Company shall, to the greatest extent
                                            permitted by law, indemnify each Indemnified Party for, and hold each Indemnified Party harmless
                                            from and against, any Prejudice incurred or paid by any of them as a result of any Third
                                            Party Claim against such Indemnified Party in which such Indemnified Party may become involved
                                            (whether as a party or otherwise) (whether before or after the Separation Effective Time)
                                            that has arisen in connection with such Indemnified Party's function, position, mandate or
                                            conduct as an INED, executive Director, Officer or member of the executive management of
                                            the Company, in furtherance of the Separation (including such Indemnified Party&rsquo;s conduct
                                            in negotiating and/or approving the Separation or taking any action contemplated by this
                                            Agreement or the Separation), except to the extent it is finally determined by a court of
                                            competent jurisdiction that such Prejudice has arisen (and then only to such extent) as a
                                            result of the Indemnified Party's wilful misconduct or gross negligence, as the case may
                                            be; <I>provided</I> that the Company obligation pursuant to this paragraph (d)&nbsp;in relation
                                            to the Prejudice suffered by such Indemnified Party shall be limited to the full amount of
                                            the Prejudice suffered by Indemnified Party and in relation to which the Indemnified Party
                                            can seek indemnification from the Company pursuant to this paragraph (d)&nbsp;multiplied
                                            by a fraction of which (x)&nbsp;the numerator is equal to the amount of the cash (as defined
                                            in Schedule 1) remaining with the Company immediately after the Separation Effective Time
                                            and (y)&nbsp;the denominator is the sum of the Initial SpinCo Capital Allocation as determined
                                            in accordance with the rules&nbsp;and principles set out in Part&nbsp;2 of Schedule 1) plus
                                            the amount of the cash (as defined in Schedule 1) remaining with the Company immediately
                                            after the Separation Effective Time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(e)</TD><TD STYLE="text-align: justify">Parties agree that a proposal to provide
                                            a discharge from liability for the directors of the Company in relation to the Separation,
                                            the preparation, and implementation thereof shall be submitted to the EGM of the Company
                                            to approve the Separation, as part of the as part of the proposal to approve the Separation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>8.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Transitional
                                            Services</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">Prior to the Separation, the Company shall
                                            agree with SpinCo (acting through the SpinCo Management) the services to be provided by the
                                            Company to SpinCo during a reasonable transitional period after the Separation Effective
                                            Time, subject to the prior written approval of Investor (not to be unreasonably withheld)
                                            (the &quot;<B>Transitional Services</B>&quot;). The purpose of such Transitional Services
                                            is to facilitate SpinCo operations post-Separation and allow SpinCo to operate on a stand-alone
                                            basis as soon as reasonably possible. The Company and SpinCo shall determine in good faith
                                            the scope, type and duration of the respective Transitional Services, provided that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(i)</TD><TD STYLE="text-align: justify">such Transitional Services shall be provided
                                            on at arm's length terms and invoiced on a cost-plus basis;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(ii)</TD><TD STYLE="text-align: justify">the underlying documentation for the
                                            Transitional Services shall contain reasonable termination provisions for either party;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(iii)</TD><TD STYLE="text-align: justify">the service levels for the provision
                                            of the Transitional Services shall not exceed the service levels applicable to the services
                                            provided to the Company at the Agreement Date; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 34.3pt">(iv)</TD><TD STYLE="text-align: justify">the Company shall only be obligated to
                                            perform such Transitional Services to the reasonable extent that it has the resources to
                                            do so.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">The Company shall, and shall cause that
                                            SpinCo shall, use reasonable endeavours to, and to undertake all reasonable steps to, prepare
                                            SpinCo to be operationally ready as of, or promptly following, the Separation Effective Time,
                                            including (as relevant) obtaining all material permits, setting up relevant technology systems,
                                            establishing bank accounts, arranging for independent lease arrangements to be entered into,
                                            or anything else required for the business to operate as an independent going concern.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>9.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Adherence
                                            by SpinCo</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company may (at its discretion)
cause, following the Agreement Date, SpinCo to adhere to this Agreement by delivering a duly executed copy of the Adherence Letter to
each of the Parties. The Parties agree that upon such delivery, (i)&nbsp;SpinCo shall become a Party to this Agreement (and any reference
to 'Party' or 'Parties' shall also include SpinCo), (ii)&nbsp;SpinCo will be directly bound by the obligations, covenants and commitments
that are contemplated by this Agreement to be binding upon SpinCo or that the Company is to cause SpinCo to do or agree to (without prejudice
to the Company guaranteeing until the Separation Effective Time the due and timely performance by SpinCo of all such obligations, covenants,
commitments actions), (iii)&nbsp;the other Parties can directly enforce such obligations, covenants and commitments against SpinCo, and
(iv)&nbsp;SpinCo may directly rely on this Agreement against the other Parties to the extent relevant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>10.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Company
                                            Intellectual Property</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company shall cause that, with
effect as from the Separation Effective Time, SpinCo shall (and shall cause its Subsidiaries to):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">cease to use or display (including, without
                                            limitation, on or in its business stationery, documents, signs, promotional materials, social
                                            media or website) the Company's intellectual property (including any name, mark or logo)
                                            (&quot;<B>Company Intellectual Property</B>&quot;) which is the same as or similar to, or
                                            is likely to be confused or associated with, any trade mark of the Company or any of its
                                            Subsidiaries;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">have submitted all forms and taken all
                                            steps as is necessary to change SpinCo's name to a name that does not include any Company
                                            Intellectual Property or anything confusingly similar; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">not hold itself out or otherwise represent
                                            itself to be a member of, or to be associated or connected with any member or business venture
                                            of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>11.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Convertible
                                            Loan by SpinCo to the Company</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Effective as of the Separation
Effective Time, and unless the Company elects otherwise, the Company and SpinCo will enter into a definitive agreement pursuant to
which SpinCo will provide the Company with a financing backstop facility of up to [&hellip;***&hellip;] (&quot;<B>Backstop Facility Agreement</B>&quot;). The Backstop Facility Agreement will reflect the terms set out in
Schedule 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>12.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Further
                                            Assurance</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Subject to the Conditions Precedent,
each of the Parties shall use reasonable efforts to take all actions and do all things necessary, proper or advisable to consummate the
transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>13.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Confidentiality
                                            and Announcements</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.1.</B></TD><TD STYLE="text-align: justify"><B>Confidential Information</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For the purposes of this Agreement,
&quot;<B>Confidential Information</B>&quot; means, subject to Article&nbsp;13.1(a)&nbsp;through Article&nbsp;13.1(d), (i)&nbsp;with respect
to any Party, all information regarding such Party or its Affiliates that is disclosed by or on behalf of such Party or any of its Affiliates
to the other Parties or any of their Affiliates under this Agreement. Except to the extent expressly authorized by this Agreement or
otherwise agreed in writing by the Parties, each Party agrees that, for a period of ten (10)&nbsp;years, it shall, and shall cause its
Affiliates to, keep confidential and not publish or otherwise disclose, and not use for any purpose other than as provided for in this
Agreement, any Confidential Information of another Party or any of its Affiliates. Notwithstanding the foregoing, Confidential Information
of a Party or its Affiliates shall exclude that portion of such information that a receiving Party (or the receiving Party's applicable
Affiliate) (&quot;<B>Receiving Party</B>&quot;) can demonstrate by competent written proof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">was already known to the Receiving Party
                                            or its Affiliate, other than under an obligation of confidentiality, at the time of disclosure
                                            to the receiving Party or its Affiliate;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">was generally available to the public
                                            or part of the public domain at the time of its disclosure to the Receiving Party or its
                                            Affiliate;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">was subsequently disclosed to the Receiving
                                            Party or its Affiliate by a Third Party without obligations of confidentiality with respect
                                            thereto; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(d)</TD><TD STYLE="text-align: justify">was independently discovered or developed
                                            by the Receiving Party or its Affiliate without the aid, application, or use of any of the
                                            other Party's Confidential Information,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>provided that</I> specific disclosures
made under this Agreement shall not be deemed to be subject to any of the foregoing exceptions merely because they are embraced by general
disclosures in the public knowledge or literature or in the possession of the Receiving Party or its Affiliates, and any combination
of features disclosed under this Agreement shall not be deemed subject to the above exceptions merely because individual features are
in the public knowledge or literature or in the possession of the Receiving Party or its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.2.</B></TD><TD STYLE="text-align: justify"><B>Confidentiality</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Each Receiving Party shall treat as
strictly confidential and shall not disclose any Confidential Information, provided that these restrictions shall not apply to any disclosure
of Confidential Information, if and to the extent such disclosure is:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">required by applicable law;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">required by any governmental authority
                                            or tax authority to which the relevant Party is subject;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(c)</TD><TD STYLE="text-align: justify">required in the framework of any proceedings
                                            under Article&nbsp;15.2(b);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(d)</TD><TD STYLE="text-align: justify">made to the Receiving Party's Affiliates
                                            or the Receiving Party's or its Affiliates' Party's representatives, (subject however to
                                            such Affiliates, representatives, professional advisors and auditors agreeing to keep and
                                            keeping all such documents and information confidential in accordance with this Article&nbsp;13.2);
                                            or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(e)</TD><TD STYLE="text-align: justify">of information that has already come into
                                            the public domain through no fault of the Receiving Party or any of its Affiliates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.3.</B></TD><TD STYLE="text-align: justify"><B>Announcements</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">The initial press release with respect
                                            to the Separation shall be the Announcement in the agreed form as attached hereto as Schedule
                                            3. Other than such Announcement, no Party shall issue any press release or public announcement
                                            with respect to this Agreement, without the prior written approval of the other Parties (which
                                            consent shall not be unreasonably withheld, conditioned or delayed), except where such press
                                            release or public announcement is required by any applicable law, any competent securities
                                            exchange, supervisory, regulatory or governmental body, or any court order; <U>provided</U>
                                            that the foregoing shall not apply to any press release or public announcement so long as
                                            any statements contained therein concerning the Separation or the other transactions contemplated
                                            by this Agreement are consistent with previous releases or announcements made by the applicable
                                            Party with respect to which such Party has complied with the provisions of this Article&nbsp;13.3.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">If a press release or public announcement
                                            is required by any applicable law or any competent governmental authority, then prior to
                                            any such press release or public announcement, the Party required to make such press release
                                            or announcement shall, to the extent possible, consult with the other Party as to how to
                                            avoid or limit the disclosure, and such Party shall only make such disclosure that it is
                                            legally required to make.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.4.</B></TD><TD STYLE="text-align: justify"><B>Filings</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Parties acknowledge that a Party
may be obligated to make a filing (including to file a copy of this Agreement) with the SEC or other governmental authorities. Each Party
shall be entitled to make such a required filing, <I>provided that</I> it shall agree (such agreement not to be unreasonably withheld,
conditioned or delayed) with the other Parties in advance regarding such filing. If the Parties agree that any portion of an agreement
shall be redacted pursuant to a confidential treatment request or otherwise, then the Parties further agree to: (i)&nbsp;promptly deliver
to the other Parties any written correspondence received by it or its representatives from such governmental authority with respect to
such confidential treatment request and promptly advise the other Parties of any other material communications between it or its representatives
with such governmental authority with respect to such confidential treatment request, (ii)&nbsp;upon the written request of the other
Parties, if legally justifiable, request an appropriate extension of the term of the confidential treatment period, and (iii)&nbsp;if
such governmental authority requests any changes to the redactions, use commercially reasonable efforts consistent with applicable laws
to support the redactions as originally filed and not agree to any changes to the redactions without, to the extent practical, first
discussing such changes with the other Parties and taking the other Parties' comments into consideration when deciding whether to agree
to such changes. Each Party shall be responsible for its own legal and other external costs and expenses in connection with any such
filing, registration or notification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>14.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Miscellaneous</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>14.1.</B></TD><TD STYLE="text-align: justify"><B>No Assignment</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Except with the prior written consent
of the other Parties or except as expressly provided for in this Agreement, no Party hereto shall be entitled to transfer or assign any
of its rights or obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>14.2.</B></TD><TD STYLE="text-align: justify"><B>Entire Agreement</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">This Agreement contains the entire
agreement between the Parties in respect of its subject matter. It replaces and annuls all prior agreements, communications, offers,
proposals or correspondence, oral or written, exchanged or concluded between the Parties relating to the same subject matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>14.3.</B></TD><TD STYLE="text-align: justify"><B>Severability</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">If any provision in this Agreement is
                                            held to be illegal, invalid or unenforceable, in whole or in part, under any applicable law,
                                            then such provision or part of it shall be deemed not to form part of this Agreement, and
                                            the legality, validity or enforceability of the remainder of this Agreement shall not be
                                            affected.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">In such case, each Party shall use reasonable
                                            efforts to negotiate in good faith a valid replacement provision that is as close as possible
                                            to the original intention of the Parties and has the same or as similar as possible economic
                                            effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Absent a replacement by the Parties in
                                            accordance with Article&nbsp;14.3(b), the relevant provision shall automatically be replaced
                                            by a provision that is legal, valid and enforceable that is as close as possible to the original
                                            intention of the Parties and has the same or as similar as possible economic effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>14.4.</B></TD><TD STYLE="text-align: justify"><B>Notices</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Any notice required or permitted to
be given under this Agreement shall be in writing, shall specifically refer to this Agreement, and shall be addressed to the appropriate
Party at the address specified below or such other address as may be specified by such Party in writing in accordance with this Article&nbsp;14.4,
(or as set out in any Adherence Letter delivered by a Party) and shall be deemed to have been given for all purposes (a)&nbsp;when received,
if hand-delivered, sent by a reputable international expedited delivery service or sent by facsimile (with transmission confirmed), or
(b)&nbsp;five (5)&nbsp;Business Days after mailing, if mailed by first class certified or registered mail, postage prepaid, return receipt
requested. Any notice delivered by facsimile shall be confirmed by a hard copy delivered by a reputable international expedited delivery
service as soon as practicable thereafter. This Article&nbsp;14.4 is not intended to govern the day-to-day business communications necessary
between the Parties in performing their obligations under the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.7in; width: 32%; font-size: 10pt"><FONT STYLE="font-size: 10pt">If to Galapagos
    NV:</FONT></TD>
    <TD STYLE="width: 68%; font-size: 10pt"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">Galapagos NV<BR>
                                            Generaal De Wittelaan L11 A3<BR> 2800 Mechelen<BR> Belgium<BR> Attention: Chief Executive
                                            Officer<BR> Fax: +32 15 342 901</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.7in; font-size: 10pt"><FONT STYLE="font-size: 10pt">With a copy to (which shall
    not constitute notice):</FONT></TD>
    <TD STYLE="font-size: 10pt"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">Galapagos NV<BR> Generaal De
                                Wittelaan L11 A3<BR> 2800 Mechelen<BR> Belgium<BR> Attention: General Counsel<BR> legal@glpg.com</FONT></P>
                                                                           <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0.7in; font-size: 10pt"><FONT STYLE="font-size: 10pt">If to Gilead Therapeutics
    A1 Unlimited Company:</FONT></TD>
    <TD STYLE="font-size: 10pt"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">Gilead Therapeutics A1 Unlimited
                                Company<BR> c/o Gilead Sciences,&nbsp;Inc.<BR> 333 Lakeside Drive<BR> Foster City, CA 94404 USA<BR> Attention:
                                President and Chief Operating Officer<BR> Facsimile: +1 (650) 577-6762</FONT></P>
                                                                           <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">Gilead Therapeutics A1 Unlimited
                                Company<BR> c/o Gilead Sciences,&nbsp;Inc.<BR> 333 Lakeside Drive<BR> Foster City, CA 94404 USA<BR> Attention:
                                General Counsel<BR> Facsimile: +1 (650) 522-5771</FONT></P>
                                                                           <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.7in; font-size: 10pt"><FONT STYLE="font-size: 10pt">With copies to (which shall
    not constitute notice):</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Wachtell, Lipton, Rosen&nbsp;&amp; Katz</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">51 West 52nd Street</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10019</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Daniel A. Neff and David K. Lam</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Facsimile: +1 (212) 403-2000</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Eubelius<BR>
    Louizalaan 99 Av. Louise<BR>
    BE-1050 Brussels<BR>
    Attention: Joris De Wolf<BR>
    Facsimile: +32 2 543 31 01</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>14.5.</B></TD><TD STYLE="text-align: justify"><B>Counterparts</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">This Agreement may be signed in counterparts,
in the number of originals stated hereinafter on the signature page. When taken together, the counterparts signed by all Parties shall
constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>14.6.</B></TD><TD STYLE="text-align: justify"><B>Electronic Signature</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Parties expressly agree that this
                                            Agreement may be signed with the handwritten signature of the Parties or with the electronic
                                            signatures of the same, whether such signatures qualify as advanced or qualified electronic
                                            signatures in the sense of the eIDAS Regulation EU/910/2014.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Parties expressly agree that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">electronic signatures complying with the
                                            requirements set forth by this Article&nbsp;shall have the same evidentiary and formal value
                                            as handwritten signatures for private deeds, this by deviation, as the case may arise, from
                                            Article&nbsp;8.18 of the Belgian Civil Code and from Article&nbsp;XII.25 of the Belgian Economic
                                            Law Code;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">this Agreement, once electronically signed
                                            by all the Parties, shall irrefutably deem to comply with Article&nbsp;8.9 of the Belgian
                                            Civil Code and to be a written agreement for all legal purposes; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">all faithful copies of this Agreement
                                            electronically signed by all the Parties (i.e. copies not invalidating the electronic signatures
                                            or seals at stake) shall be recognized as an original copy for all legal purposes and Article&nbsp;8.20
                                            of the Belgian Civil Code shall irrefutably be deemed satisfied by the signature of one initial
                                            original copy of this Agreement by all the Parties, this without prejudice to each Party
                                            receiving a faithful copy thereof, without the need to identify the number of such original
                                            copies in this Agreement, this by deviation, as the case may arise, from the same Article&nbsp;8.20.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>14.7.</B></TD><TD STYLE="text-align: justify"><B>Specific Enforcement</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Notwithstanding anything in this Agreement
to the contrary, nothing in this Agreement shall in any way limit the ability of a Party to seek or obtain from any court of competent
jurisdiction any remedies available at law or in equity (including injunctive relief) to enforce any covenant or agreement of the other
Party hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>14.8.</B></TD><TD STYLE="text-align: justify"><B>Non-contractual liability</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">To the fullest extent permitted by
Law, the Parties waive making any non-contractual claims against each other and against (direct and indirect) auxiliary persons of another
Party for damages resulting from non-performance of an obligation under this Agreement. These auxiliary persons are third-party beneficiaries
of this provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>15.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Governing
                                            Law and Dispute Resolution</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>15.1.</B></TD><TD STYLE="text-align: justify"><B>Governing Law</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">This agreement and any non-contractual
obligations arising out of or in connection with it shall be governed by and construed in accordance with Belgian law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>15.2.</B></TD><TD STYLE="text-align: justify"><B>Dispute Resolution</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(a)</TD><TD STYLE="text-align: justify">It is the objective of the Parties to
                                            establish procedures to facilitate the resolution of disputes arising under this Agreement
                                            in an expedient manner by mutual cooperation and without resort to litigation. In the event
                                            of any disputes, controversies or differences which may arise between the Parties out of
                                            or in relation to or in connection with this Agreement, including any alleged failure to
                                            perform, or breach, of this Agreement, or any issue relating to the interpretation or application
                                            of this Agreement, then upon the request of a Party by written notice, the Parties agree
                                            to meet and discuss in good faith a possible resolution thereof, which good faith efforts
                                            shall include at least one in-person meeting between the Chief Executive Officer of the Company
                                            and the Chief Executive Officer of the Parent Investor. If the matter is not resolved within
                                            thirty (30) days following the written request for discussions, any Party may then invoke
                                            the provisions of Article&nbsp;15.2(b).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.9pt">(b)</TD><TD STYLE="text-align: justify">Any dispute, controversy, difference or
                                            claim which may arise between the Parties out of or in relation to or in connection with
                                            this Agreement (including arising out of or relating to the validity, construction, interpretation,
                                            enforceability, breach, performance, application or termination of this Agreement) that is
                                            not resolved pursuant to Article&nbsp;15.2(a), shall be settled by binding arbitration in
                                            accordance with the applicable rules&nbsp;of the International Chamber of Commerce (&quot;<B>ICC
                                            Rules</B>&quot;) by three (3)&nbsp;arbitrators, one each chosen by the Company and the Parent
                                            Investor, respectively, and the third chosen by mutual agreement of the first two, and otherwise
                                            in accordance with the ICC Rules. The arbitrators shall have significant experience and shall
                                            have expertise in Belgian corporate law. Any Party, following the end of the thirty (30)
                                            day period referenced in Article&nbsp;15.2(a), may refer such issue to arbitration by submitting
                                            a written notice of such request to the other Parties. The place of arbitration shall be
                                            New York and the language (including all testimony, evidence and written documentation) shall
                                            be English. The arbitrators shall establish procedures to facilitate and complete such arbitration
                                            as soon and efficiently as practicable. Unless the arbitrators expressly determine otherwise,
                                            no Party shall be required to give general discovery of documents, but may be required only
                                            to produce specific, identified documents which are relevant to the dispute. The Parties
                                            shall have the right to be represented by counsel. Any judgment or award rendered by the
                                            arbitrators shall be final and binding on the Parties, and shall be governed by the terms
                                            and conditions hereof. The Parties agree that such a judgment or award may be enforced in
                                            any court of competent jurisdiction. The statute of limitations of Belgian law applicable
                                            to the commencement of a lawsuit shall apply to the commencement of arbitration under this
                                            Article&nbsp;15.2(b). The arbitrators shall determine the allocation of costs and expenses
                                            and attorneys' fees in the arbitration to be borne by each Party. All proceedings and decisions
                                            of the arbitrators shall be deemed Confidential Information of each of the Parties, and shall
                                            be subject to Article&nbsp;13.2 of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature pages&nbsp;follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>IN WITNESS WHEREOF<I>,</I></B> the Parties
hereto have initialled each page&nbsp;of this Agreement, and have signed and executed this Agreement on the day and year first written
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 4%; text-align: left"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>(1)</B></FONT></TD><TD STYLE="text-align: justify; width: 96%"><FONT STYLE="font-size: 10pt"><B>GALAPAGOS
                                            NV</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 40%; text-align: justify">/s/ Paul Stoffels</TD>
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 46%; text-align: justify">/s/ J&eacute;r&ocirc;me Contamine</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Stoffels IMC BV, permanently represented by Dr. Paul Stoffels</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">J&eacute;r&ocirc;me Contamine</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Chair of the Board of Directors and CEO</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Lead Non-Executive Independent Director</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[signature page&nbsp;to
Separation Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 4%; text-align: left"><FONT STYLE="font-size: 10pt"><B>(2)</B></FONT></TD><TD STYLE="text-align: justify; width: 96%"><FONT STYLE="font-size: 10pt"><B>GILEAD
                                            THERAPEUTICS A1 UNLIMITED COMPANY</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 40%; text-align: justify">/s/ Aoife Marrinan</TD>
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 46%; text-align: justify"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Aoife Marrinan</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Director</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>[signature page&nbsp;to
Separation Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 4%; text-align: left"><FONT STYLE="font-size: 10pt"><B>(3)</B></FONT></TD><TD STYLE="text-align: justify; width: 96%"><FONT STYLE="font-size: 10pt"><B>GILEAD
                                            SCIENCES,&nbsp;INC.</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 40%; text-align: justify">/s/ Devang Bhuva</TD>
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 46%; text-align: justify"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Devang Bhuva</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">SVP, Corporate Development &amp; Alliance Management</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"></TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>[signature page&nbsp;to
Separation Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Schedule
1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Separation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>Part&nbsp;1.</U></B></FONT><B>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Pre-Separation
Completion Steps</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD><B>Incorporation of SpinCo</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company intends to incorporate
SpinCo in accordance with the provisions of this Agreement as soon as practicable possible after the Agreement Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><B>Corporate filings, publications and submissions
                                            by the Company</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company shall put in place the
following reports and documentation, and make the following filings and publications:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Execution of a partial demerger proposal
                                            for the Separation in accordance with Article&nbsp;12:59 of the Belgian Companies and Associations
                                            Code</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Filing of the partial demerger proposal
                                            for the Separation with the competent enterprise court</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Publication of the partial demerger proposal
                                            for the Separation in accordance with applicable laws and regulations</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Execution of a partial demerger report
                                            of the Board of Directors of the Company in accordance with Article&nbsp;12:61 of the Belgian
                                            Companies and Associations Code</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">Delivery by the statutory auditor of Company
                                            of a partial demerger report in accordance with Article&nbsp;12:62, &sect;1 of the Belgian
                                            Companies and Associations Code</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">Execution of a report of the Board of
                                            Directors of SpinCo in accordance with Articles 7:180, 7:191 and 7:193 of the Belgian Companies
                                            and Associations Code in relation to the BiotechCo Warrant (if applicable)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">Delivery by the statutory auditor of SpinCo
                                            of a partial demerger report in accordance with Article&nbsp;7:180, 7:191 and 7:193 of the
                                            Belgian Companies and Associations Code in relation to the BiotechCo Warrant (if applicable)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">Execution of a report of the Board of
                                            Directors of SpinCo in accordance with Articles 7:180, 7:191 and 7:193 of the Belgian Companies
                                            and Associations Code in relation to the BiotechCo Subscription Rights (if applicable)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Delivery by the statutory auditor of SpinCo
                                            of a partial demerger report in accordance with Article&nbsp;7:180, 7:191 and 7:193 of the
                                            Belgian Companies and Associations Code in relation to the BiotechCo Subscription Rights
                                            (if applicable)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">Execution of a report of the Board of
                                            Directors of SpinCo in accordance with Articles 7:199 of the Belgian Companies and Associations
                                            Code in relation to the authorised capital (if applicable)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify">Comply with the information obligations
                                            in accordance with Article&nbsp;12:63 of the Belgian Companies and Associations Code</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify">Making available the required documents
                                            in accordance with Articles 12:64 and 12:67 of the Belgian Companies and Associations Code</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><B>Corporate filings, publications and submissions
                                            by SpinCo</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company shall cause that SpinCo
put in place the following reports and documentation, and make the following filings and publications:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Execution of a partial demerger proposal
                                            for the Separation in accordance with Article&nbsp;12:59 of the Belgian Companies and Associations
                                            Code</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Filing of the partial demerger proposal
                                            for the Separation with the competent enterprise court</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Publication of the partial demerger proposal
                                            for the Separation in accordance with applicable laws and regulations</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Execution of a partial demerger report
                                            of the Board of Directors of SpinCo in accordance with Article&nbsp;12:61 of the Belgian
                                            Companies and Associations Code</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">Delivery by the statutory auditor of SpinCo
                                            of a partial demerger report in accordance with Article&nbsp;12:62, &sect;1 of the Belgian
                                            Companies and Associations Code</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">Execution of a report of the Board of
                                            Directors of SpinCo in accordance with Articles 7:180, 7:191 and 7:193 of the Belgian Companies
                                            and Associations Code in relation to the SpinCo Warrant (if applicable)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">Delivery by the statutory auditor of SpinCo
                                            of a partial demerger report in accordance with Article&nbsp;7:180, 7:191 and 7:193 of the
                                            Belgian Companies and Associations Code in relation to the SpinCo Warrant (if applicable)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">Execution of a report of the Board of
                                            Directors of SpinCo in accordance with Articles 7:180, 7:191 and 7:193 of the Belgian Companies
                                            and Associations Code in relation to the SpinCo Subscription Rights (if applicable)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Delivery by the statutory auditor of SpinCo
                                            of a partial demerger report in accordance with Article&nbsp;7:180, 7:191 and 7:193 of the
                                            Belgian Companies and Associations Code in relation to the SpinCo Subscription Rights (if
                                            applicable)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">Execution of a report of the Board of
                                            Directors of SpinCo in accordance with Articles 7:199 of the Belgian Companies and Associations
                                            Code in relation to the authorised capital (if applicable)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify">Comply with the information obligations
                                            in accordance with Article&nbsp;12:63 of the Belgian Companies and Associations Code</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify">Prepare interim financial statements of
                                            SpinCo in accordance with Article&nbsp;12:64, &sect;2 of the Belgian Companies and Associations
                                            Code (if applicable)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(m)</TD><TD STYLE="text-align: justify">Making available the required documents
                                            in accordance with Articles 12:64 and 12:67 of the Belgian Companies and Associations Code</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><B>Other filings and submissions</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Company shall make the necessary filings
                                            in order to obtain the Tax Ruling(s).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Company shall prepare the Listing
                                            Documentation and the Company and/or SpinCo shall make the Listing Filings as required pursuant
                                            to Article&nbsp;5.4</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">The Company shall, and shall cause its
                                            Subsidiaries to, inform and/or consult their respective personnel in due time in accordance
                                            with applicable labour laws</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify"><B>SpinCo approval</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company shall cause that an EGM
of SpinCo approves the Separation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify"><B>Convening of an EGM</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company shall, with a view to the
approval of the Separation, convene an EGM in accordance with applicable laws and regulations as soon as practicably possible when it
shall have sufficient comfort that all of the Conditions Precedent (for the avoidance of doubt, other than the Company EGM Condition)
shall be satisfied as contemplated by the terms of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If the EGM shall not be a Quorate EGM,
the Company shall again, with a view to the approval of the Separation, convene a second EGM with the same agenda such that such EGM
shall be a Quorate EGM due to the absence of any legal requirement in terms of the number of shares present or represented at the EGM.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Private and Confidential</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Execution copy</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>Part&nbsp;2.</U></B></FONT><B>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Capital
Allocation</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD><B>Initial SpinCo Capital Allocation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">SpinCo will be allocated an initial cash
                                            amount (&quot;<B>Initial SpinCo Capital Allocation</B>&quot;) equal to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">&euro;2,450,000,000; <I>minus</I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">if any, 50% of any additional costs and
                                            expenses incurred by the Company after 30 June&nbsp;2025 and prior to the Separation for
                                            any third-party advisory fees and services related to the Separation as a result of the Separation
                                            occurring after 30 June&nbsp;2025 (the &quot;<B>Additional Shared Expenses</B>&quot;), <I>plus</I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">50% of the amount of cash, if any, held
                                            by the Company immediately prior to the Separation Effective Time that is in excess of &euro;3,000,000,000.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">For the avoidance of doubt, in no event
will the Initial InvestCo Capital Allocation be less than an amount equal to (x)&nbsp;&euro;2,450,000,000 <I><U>minus</U></I> (y)&nbsp;50%
of the Additional Shared Expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">For purposes of this Agreement, &quot;cash&quot;
                                            includes cash and all cash equivalents; provided that, for purposes of calculating the Initial
                                            SpinCo Capital Allocation, &quot;cash&quot; shall not include any cash or cash equivalents
                                            that is, directly or indirectly, subject to restrictions or limitations on use, transfer
                                            or distribution by law, contract or otherwise, including restrictions on declaration or payment
                                            of dividends or similar distributions, security deposits, bond guarantees, cash or cash equivalents
                                            held in escrow, collateral for letters of credit or similar financial assurances, repatriations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">The Parties agree that, for tax and accounting
                                            purposes, the Separation will be carried out with retroactive effect as from 1 April&nbsp;2025,
                                            and, therefore, the Initial SpinCo Capital Allocation shall be treated as having transferred
                                            to SpinCo as of 1 April&nbsp;2025. Any interest that shall accrue on an amount of cash equal
                                            to the Initial SpinCo Capital Allocation from 1 April&nbsp;2025 to the Separation Effective
                                            Time shall be treated as an Excluded Asset and shall not be transferred from the Company
                                            to SpinCo as part of the Separation, and the Company shall bear any tax liability with respect
                                            to such interest for such period of time, it being understood that, in all events, SpinCo
                                            shall receive an amount of cash at the Separation Effective Time (after taking into account
                                            any taxes that may be owed by SpinCo for any period prior to the Separation Effective Time)
                                            equal to Initial SpinCo Capital Allocation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD><B>Initial Company Capital Allocation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Subject to the last sentence of Section&nbsp;1(c)&nbsp;of
this Part&nbsp;2 of Schedule 1, at the Separation Effective Time, the Company shall be allocated an initial cash amount equal to (i)&nbsp;the
amount of cash held by Company immediately prior to the Separation <I><U>minus</U></I> (ii)&nbsp;the Initial SpinCo Capital Allocation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
